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DYNAMIC CHEMICAL SHIFT IMAGING FOR IMAGE-
GUIDED THERMAL THERAPY 
Brian Allen Taylor, B.S. 
Supervisory Professor: R. Jason Stafford, Ph.D.  
Magnetic resonance temperature imaging (MRTI) is recognized as a noninvasive 
means to provide temperature imaging for guidance in thermal therapies.  The most 
common method of estimating temperature changes in the body using MR is by 
measuring the water proton resonant frequency (PRF) shift.  Calculation of the complex 
phase difference (CPD) is the method of choice for measuring the PRF indirectly since it 
facilitates temperature mapping with high spatiotemporal resolution.  Chemical shift 
imaging (CSI) techniques can provide the PRF directly with high sensitivity to 
temperature changes while minimizing artifacts commonly seen in CPD techniques.  
However, CSI techniques are currently limited by poor spatiotemporal resolution.   
This research intends to develop and validate a CSI-based MRTI technique with 
intentional spectral undersampling which allows relaxed parameters to improve 
spatiotemporal resolution.  An algorithm based on autoregressive moving average 
(ARMA) modeling is developed and validated to help overcome limitations of Fourier-
based analysis allowing highly accurate and precise PRF estimates.  From the determined 
acquisition parameters and ARMA modeling, robust maps of temperature using the k-
means algorithm are generated and validated in laser treatments in ex vivo tissue.  The use 
of non-PRF based measurements provided by the technique is also investigated to aid in 
the validation of thermal damage predicted by an Arrhenius rate dose model.   
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Chapter 1: Introduction 
1.1 Thermal Therapies 
Thermal therapies generally encompass all treatments based on the transfer of 
thermal energy out of or into the body.  The overall objective of these therapies is to 
deliver a desired thermal dose to a target while minimizing the dose to normal tissues (1).  
The use of thermal energy in medicine is not a new concept.  During the reign of the 
Roman Empire, facilities were created which contained hot baths in addition to the use of 
dry and humid heat to treat diseases.  An Egyptian papyrus, dated at approximately 3000 
BC, described the use of heat in surgery and is possibly the earliest manuscript known in 
thermal therapy.  In the nineteenth and twentieth centuries, “fever therapy” was 
investigated to improve the immune response in certain pathologies (2). 
The more modern discipline of thermal therapies came mostly from laboratories 
in the 1970s that were interested in radiation biology and how temperature affects the 
radio-sensitivity of cells (3).    A number of cell culture and in vivo tumor model studies 
showed a cell-killing effect at temperatures above 41 °C (4).  It was also found that the 
exposure time to kill cells was shorter when higher temperatures were used.  In the 
1980s, key studies were reported that assessed the efficacy of thermal therapies (4-7).  
The concept of thermal dosimetry was also introduced (8).   
Although there were modest improvements in the ways to deliver heat into 
tissues, the enthusiasm for these treatments dwindled in the 1990s.  According to a 
review published in 2006 by Habash (1),  
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“The problem that was faced by the thermal-therapy 
community at that juncture was unrealistic thermal goals 
because of lack of adequate equipment for delivering thermal 
treatment and inability to measure the treatment delivered.  A 
combination of the above difficulties is still a challenge to the 
design and implementation of successful clinical trials.”  
Since the publication by Habash, there have been improvements in the delivery and 
monitoring of these therapies (3).  However, Habash’s review underscores the importance 
of monitoring in order for thermal therapies to be effective.   
Thermal therapies are typically divided into three categories.  In the low 
temperature range, cryotherapy is used to freeze tissue with the goal of necrosis (9). 
Hyperthermia is used where the temperature at a region of the body or the whole body is 
raised to temperatures up to approximately 45 °C for an extended period of time (minutes 
to hours) (10).  Another category is thermal ablation where very high temperatures 
(typically >50 °C) are used to destroy tissue in a conformal setting (3).   
   The main biological rationale for thermal therapies is based on cell-killing (4).  
Studies have shown that protein denaturation is the most likely mechanism that causes 
permanent damage to tissue (4, 11-14).  When proteins denature, they are prone to 
aggregation.   Without any molecular chaperones to aid in refolding the proteins, these 
aggregated proteins can affect the structure and function of many macromolecules that 
are vital for the cell’s survival (4, 15).   
   The aggregation of proteins caused by hyperthermic temperatures is thought to be 
key to cells being more sensitive to radiation (12) and the efficacy of using both radiation 
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and thermal therapy is higher the closer the two are given in time.    If there is a delay of 
radiation after thermal treatment, heat shock protein levels are higher and more proteins 
are repaired and less aggregated making the cells more insensitive to radiation (16).  
There is also an additive effect using hyperthermia and radiation.  Cells which are 
hypoxic, have low pH values, and are in the S-phase in the cell cycle are sensitive to heat 
and are relatively resistant to radiation.  Hyperthermia can also increase the blood 
perfusion into cells thereby decreasing hypoxia and making the cells more radiosensitive 
(17).    
 Hyperthermia has also been shown to increase the efficacy of some drugs, 
including chemotherapeutic drugs (18).   Drugs that have chemical, rate-limiting 
reactions are expected to be more efficient at higher temperatures due to thermodynamic 
principles.  For example, cisplatin alkylates DNA at a higher rate at higher temperatures, 
thereby increasing its efficacy (19).  As with radiation therapy, the increase in blood flow 
in the tumor causes increased drug uptake and concentration which can aid in cell-killing 
(18).   
 Hyperthermia has been studied used as an adjuvant in gene and immuno- 
therapies.  Gene therapy is defined as a treatment where genetic material is infused to 
cells to modify cellular function.  In cancer treatment, the material must affect cells 
associated with the tumor and not in normal tissue.  It must also not drastically affect the 
immune system in the infected patient.  Studies have shown that gene-infected cells are 
more sensitive to hyperthermia.  The increased temperature is expected to open the pores 
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of blood vessels to allow more genetic material to reach the tumor cells.  It also increases 
the protein production in the affected cells and enhances the immune system’s ability to 
send the infected cells to the tumor (20-23). 
 In hyperthermia, it is important to note the narrow temperature ranges that are 
needed for combination treatments with radiation and chemotherapy (24).  This makes 
the accurate and precise monitoring of temperature in vivo very important.  If a certain 
temperature is needed as an adjuvant to a therapy and going too high or too low in 
temperature can affect outcomes, then it is very important to have precise and accurate 
monitoring.   
The goal of thermal ablation is to destroy a lesion using a high dose of thermal 
energy (above 50 °C) in a minimally-invasive way without damaging vital nearby 
structures.  While protein denaturation does occur in this higher temperature range, and at 
a faster rate than seen in hyperthermia, the main effect seen in these therapies is 
coagulative necrosis.   This has been studied as an alternative or adjuvant to conventional 
surgery and can be used in conjunction to other treatments, such as chemotherapy and 
radiation therapy, to treat localized disease.  It can be a repeatable procedure and may be 
suited for patients who are not good candidates for open surgery.  There are also various 
modalities to deliver heat to the target including focus ultrasound (FUS), radiofrequency 
(RF) applicators, microwaves, and lasers.  The rapid heating of tissues to ablative 
temperatures requires fast monitoring in order to control the treatment, conform to the 
target and minimize thermal dose to critical normal structures (3).   
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In thermal therapies, it is important to model and determine where the thermal 
damage has occurred to verify that the target lesion has been successfully treated.  Thus, 
damage prediction models have been developed to aid in treatment verification.  In one of 
the seminal papers on thermal damage, Henriques studied the thermal damage in pig skin 
(25).  He showed that the thermal damage from the denaturation of proteins follows an 
Arrhenius rate process.  The rate process can be described as a rate-of-formation kinetic 
model of reaction products in a biochemical reaction.   Briefly, molecules like proteins in 
their native state, C, must reach an energy barrier, Ea, to be activated, C*, at a rate ka.  
Some will relax back to the native state while some will denature at rate kd.  This 
denaturation rate can be described as  
*G
RT
d
RTk e
N
−∆
=
h
      (1.1) 
where R is the universal gas constant (8.315 JK-1mol-1
 
or
 
2.0 cal K-1mol-1), T is the 
temperature, N is Avogandro’s number, and ħ is Plank’s constant.  The speed of the 
reaction is governed by Gibb’s free energy of formation, ∆G*.  ∆G*= ∆H*-T ∆S* where 
∆H* is the enthalpy of activation and ∆S* is the entropy of activation.  ∆H* has an 
activation energy, Ea, where ∆H* = Ea – nRT and n is the order of the reaction.  Ea>>RT, 
thus 
* * * aEH S H
RT R RT RT
d
RTk e e Ae Ae
N
−−∆ ∆ −∆
= = =
h
    (1.2) 
kd can be expressed by a first-order Bernoulli differential equation where  
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



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0
)(
)(
)0(ln            (1.4) 
where A is the frequency factor and T(τ) is the temperature in degrees Celsius as a 
function of time, τ (26).  Henriques selected rate coefficients so complete cellular 
damage is indicated by an Ω value of unity.  Subsequent studies followed the one 
reported by Henriques and investigated parameters for various temperature ranges and 
tissues (27).   
 Almost 40 years later, Separato and Dewey proposed a method of measuring 
thermal dose as an unit of time at 43 °C (8).  The cumulative time equivalent at 43 °C, t43, 
can be described as  
 
( ) tRt
ft
t
T ∆=∑
=
−
0
43
43      (1.7) 
where tf is the final time point, T is the average temperature at time interval t∆ , and R is 
a constant (R=0.25 below 43 °C and R=0.5 at 43 °C and above).    
 The dependence of accurate and precise temperature measurements are evidently 
seen in these models.  Not only does the temperature need to be ascertained but also the 
temperature history over several time points.  This makes temperature monitoring very 
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important to accurately determine if and where thermal damage has occurred.  A 
temperature error of 1 °C over several minutes can cause the estimated thermal dose to be 
different than what was actually delivered.  This may cause an over-treatment or under-
treatment of the target.  In addition, rapid monitoring is especially needed for high-
temperature ablations to assure that temperatures are high enough to ablate the target as 
well as to make sure nearby critical structures receive nonlethal thermal doses.  This calls 
for accurate and precise methods to measure temperature noninvasively to aid in assuring 
that an acceptable thermal dose is delivered.  This is where image-guidance becomes 
important.   
1.2 Image-Guidance of Thermal Therapies 
Image-guidance has been shown to be critical in thermal therapies by providing 
localization, planning, and post-treatment verification.  In addition, image-guidance 
provides the potential for real-time monitoring during treatment delivery which can help 
better conform thermal doses to the target while avoiding nearby critical structures and 
healthy tissue  (28).   
Ultrasound (US) (29), computerized tomography (CT) (30), and magnetic 
resonance (MR) (31) are imaging modalities which are capable of temperature feedback 
during thermal therapy procedures.  Of these three modalities, MR has the desired 
properties of providing adequate localization, planning, and post-treatment verification 
using its wealth of soft-tissue contrast mechanisms without the use of ionizing radiation.  
MR can provide fast imaging in any plane.  Most importantly for temperature monitoring, 
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MR is fundamentally temperature sensitive since both the relaxation properties and 
chemical environment of the spin system are tied to thermally dependent processes (32).  
As a result, magnetic resonance temperature imaging (MRTI) is recognized as a primary 
way to non-invasively provide rapid, quantitative temperature imaging in various tissues 
in order to provide useful thermal dosimetry and monitoring for thermal therapy 
procedures (33).   
The most commonly employed quantitative MRTI method is based on the proton 
resonant frequency (PRF) shift (34-36), which has been established and validated as a 
technique for monitoring temperature changes for feedback and control of thermal 
therapies in a variety of anatomical sites (37).  A fast complex phase difference (CPD) 
method (38) has been the preferred method to estimate the PRF shift indirectly.  A major 
advantage of CPD techniques for PRF-based thermometry is its high spatial and temporal 
resolution (~1.5x1.5x4 mm3, <5 sec (39)).  However, there are several well-known 
limitations in this technique.  Intravoxel lipid contamination (40, 41), inter- and intra-
scan motion (42), tissue susceptibility changes (43) and static magnetic field drifts (44) 
are artifacts that are commonly encountered.     
An alternative to CPD methods is a direct method of measuring PRF shift via 
chemical shift imaging (CSI) techniques (45-48), which has several advantages over CPD 
techniques.  One is that the water proton resonant frequency is measured separately from 
other resonances whereas CPD measures the mixture of frequency components in each 
voxel resulting in a variable response.  This immediately relieves the problem of 
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intravoxel lipid contamination, which requires saturation or suppression techniques in 
CPD.  Also, the lipid signal can be used as an internal reference to account for field drifts, 
susceptibility and motion since it is relatively insensitive to temperature (37).    
Researchers have developed CSI techniques to reduce artifacts seen in CPD 
techniques.  However, these studies have constrained themselves in both sensitivity and 
spatiotemporal resolution by using interleaved shots to increase the spectral bandwidth to 
adequately sample the MR signal and keep peaks such as lipid unaliased in the spectra 
(45-47).  In addition, high receiver bandwidths are often used to shorten the echo-
readouts, and as an additional benefit, increases the spectral bandwidth to avoid aliasing.  
Use of these high bandwidths decreases the SNR and reduces the sensitivity of these 
techniques (45-47).  A high echo-train length (ETL) has also been used to implement 
Fourier-based spectral analysis, which also degrades spatiotemporal resolution (46, 47).   
 The proposed research is intended to build upon and address areas involved in 
image acquisition and frequency estimation that has limited CSI techniques for MRTI.  
We propose that by carefully undersampling the MR signal, which causes aliasing of the 
lipid peak, we can allow lower receiver bandwidths to maintain a higher SNR at higher 
spatiotemporal resolutions than previously reported.  In addition, it is hypothesized that, 
even with these relaxed parameters, the spatial, temporal and spectral resolutions 
currently used for temperature monitoring will not be severely degraded using advanced 
spectral processing techniques.  Traditionally, 32 or greater samples have been acquired 
so frequency estimates can be reliably performed using a fast Fourier transformation 
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(FFT) (45-47).   The increased number of samples comes at a cost of spatiotemporal 
resolution.  Time-domain, frequency domain, and z-domain (via the z-transform) 
approaches to spectral estimation have been shown to accurately measure frequencies 
with limited amounts of data when a priori information of the signal is known (49).  It has 
been recognized that an ideal NMR signal is characterized as an autoregressive (AR) 
process and a noisy NMR signal as an autoregressive moving average (ARMA) process 
(50).  It is expected that an ARMA modeling approach will be more robust than Fourier 
transformation since the model accounts for both exponential decay and noise (50).   The 
autoregressive property of the signal can be used to directly model the parameters of the 
signal including the PRF of each specimen in the signal.   Other parameters, such as the 
amplitude and damping factor (apparent spin-spin relaxation time, T2*) of each peak can 
be simultaneously determined (50-54).   
There are several potential advantages of implementing the proposed acquisition 
parameters and spectral processing algorithms (ARMA modeling).  One possible 
advantage is increased sensitivity to temperature changes compared to CPD techniques.  
By collecting more echoes during the same repetition time (TR) period as the single-echo 
CPD (38), this technique could potentially produce more accurate temperature estimates 
with lower uncertainty.  Additionally, the technique not only provides the ability to 
remove lipid signal across the volume without suppression or saturation pulses, but also 
provides the potential opportunity to use lipid as an internal reference for artifact 
suppression for increased accuracy and precision.   
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There also lies the opportunity with a model-based methods of observing both the 
T1-W images and T2* maps from each chemical specimen in addition to the PRF thereby 
providing multi-parametric monitoring of the treatment target.  This potentially 
culminates into an enhanced MRTI technique compared to what is now available.  In 
addition, all of this can be performed without dramatically sacrificing spatiotemporal 
resolution, which is critical for monitoring thermal therapies.   
 
1.3 Hypothesis and Specific Aims 
The hypothesis of this work is that through the use of a multi-gradient echo 
acquisition coupled with model-based spectral processing algorithms, CSI-based 
temperature maps utilizing this method can be generated with higher accuracy and 
precision compared to standard CPD techniques without sacrificing spatiotemporal 
resolution.  The specific aims of this work are to: 
1) Develop, validate and characterize via simulation a model-based spectral 
analysis algorithm for detection of water and lipid spectral frequencies with ≤ 
1.0 °C accuracy and uncertainty. 
2) Investigate the influence of various MR acquisition parameters on the 
sensitivity of detecting water and lipid frequency changes at high 
spatiotemporal resolutions for temperature imaging 
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3) Combine these approaches to acquisition and processing in order to develop 
and validate 2D temperature mapping techniques for generating more accurate 
and precise temperature estimates compared to CPD in phantom and ex vivo 
tissues. 
To accomplish these goals, a model-based spectral processing algorithm was 
developed to accurately measure the PRF of each peak in a spectrum using a constrained 
number of echoes to maintain spatiotemporal resolution.  This technique was validated 
using simulation over a range of SNR values and physiologically relevant water/lipid 
spectral parameters.  An appropriate range of acquisition parameters providing highly 
sensitive PRF estimates in a rapid acquisition with adequate spatiotemporal resolutions 
were determined (Chapter 4).  Heating experiments were performed in a water/lipid 
phantom as well as ex vivo bone marrow, brain, kidney, liver, and prostate tissue to 
validate the accuracy and precision of the temperature measurements as well as measure 
the dependence of T2* and T1-W amplitudes as a function of temperature (Chapter 5).  
Finally, a mapping algorithm that utilizes the k-means clustering algorithm was 
developed and validated to effectively provide a means by which to map water and lipid 
spectral parameters separately to aid in temperature mapping (Chapter 5).     
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Figure 1-1 Approach for rapid MR temperature imaging 
Data collected from a high spatiotemporal resolution MGE acquisition was processed via ARMA modeling 
to calculate multiple spectral parameters (PRF, T2*, amplitude).  These parameters were inputs to a k-
means clustering algorithm to separate chemical species such as water and lipid which were used to create 
highly accurate and precise temperature images.   
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Chapter 2: Magnetic Resonance Temperature Imaging 
2.1 Introduction 
MR is a fundamentally temperature-sensitive modality since the relaxation 
properties of a spin system and local chemical environment are fundamentally 
thermodynamic processes (32).  Therefore, multiple temperature-sensitive parameters are 
available; however, not all are equally useful for guiding thermal therapies.  In this 
chapter, temperature-sensitive MR parameters will be reviewed.  Focus will be given to 
the use of the proton resonant frequency (PRF) shift for temperature imaging, the 
dominant technique, via complex phase difference (CPD) and chemical shift imaging 
(CSI) techniques.   
2.2 The Temperature Sensitivity of Intrinsic MR Parameters 
There are a number of MR parameters intrinsic to tissue that can be exploited for 
temperature measurements.  Chief among them at clinical field strengths are diffusion of 
water, proton density of water, T1 and T2 relaxation times, magnetization transfer, and the 
PRF shift.  
2.2.1 MOLECULAR DIFFUSION OF WATER 
In MR, the diffusion coefficient, D, is used to describe the thermal Brownian 
motion of molecules (55).  The relationship of D to temperature is  
( )aE D
kTD e−≈                (2.1) 
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where Ea(D) is the activation energy of the diffusion of water.  From differentiation, the 
temperature dependence of water diffusion can be described as 
 
( ) ( )
2
aE D
a kTE DdD e
dT kT
−
=     (2.2) 
Therefore, if two diffusion measurements, DT and DT+∆T, are made at temperatures T and 
T+∆T, then the temperature change will be  
2
( )
T T T
a T
kT D DT
E D D
+∆ −∆ =  
 
    (2.3) 
where it is assumed that Ea(D) does not change with temperature.    
 In the clinical application of MRTI, the temperature sensitivity is quite high at 
about 2%/°C (33).  However, the temporal resolution is relatively low and measurements 
can be highly sensitive to motion.  Line-scan (56) and single shot echo-planar imaging 
(EPI) (57) has helped in reducing imaging time and in reducing artifacts due to motion.  
Also the use of the diffusion coefficient is independent of field strength.   
A compounding factor is observed when physiological changes occur in the tissue 
during the thermal delivery.  For instance, edema, protein denaturation and thermal 
coagulation can change the diffusion coefficient and these events are difficult to isolate 
from temperature changes (58).  It is also important to note that diffusion can be 
anisotropic such as in white matter tracts in the brain and muscle fibers.  Therefore, for 
accuracy, the tensor that describes the anisotropic diffusion needs to be measured which 
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increases the imaging time. It has been noted in a recent review that temperature 
measurements in adipose tissue using the diffusion coefficient is difficult due to the low 
values in lipid and different sensitivity compared to soft tissues (33).  Lipid suppression 
is recommended when diffusion measurements are used to estimate temperature changes.   
2.2.2 PROTON DENSITY 
The temperature-dependence of the proton density (PD) stems from the fact that it 
depends linearly on the equilibrium magnetization, M0, determined by the Boltzmann 
distribution where  
( )2 2 0
0 0 0
0
1
3
N I I B
PD M B
kT
γ
χ
µ
+
∝ = =
h
   (2.4) 
N is the number of spins, γ is the gyromagnetic ratio (42.58 MHz/T for hydrogen 
protons), ħ is Planck’s constant, I is the quantum number of the spin system (1/2 for 
hydrogen protons), B0 is the magnetic flux density, µ0 is the permeability of free space, k 
is the Boltzmann constant, T is the temperature (in Kelvin), and χ0 is the susceptibility.  
Note that χ0 and T has an inverse relationship.  This is known as the Curie law.    
Therefore, the change in susceptibility can be related to the temperature in PD-weighted 
images.  Note that the PD does not change with temperature but the ratio of parallel and 
antiparallel spins, which will show as a change in susceptibility (33), is temperature 
dependent.  The temperature sensitivity of PD is inversely proportional to temperature 
and ranges around -0.30 ± 0.01 %/°C from 37 to 80 °C (59).  This is a relatively low 
temperature sensitivity that requires high SNR.  To isolate effects from changes in T1, 
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very long repetition times are needed, which yields lower spatiotemporal resolution (60).  
If lower TRs are needed, it may be difficult to isolate changes in PD with the relaxation 
times (61).   
2.2.3 SPIN-LATTICE RELAXATION TIME (T1) 
The temperature-dependence of T1 has been well known from NMR studies (62) 
and was one of the earliest parameters used for MRTI (63-67).  Essentially, in tissues T1 
depends primarily on dipolar interactions during rotational and translational motion of 
molecules.  This molecular motion is temperature-dependent thus T1 can be a means to 
measure temperature.  T1 can be described by the following first-order Arrhenius rate 
process where  
1( )
1( )
aE T
kTT T e−∝      (2.5) 
and Ea(T1) is the activation energy of the relaxation.  It is known that T1 and temperature 
dependence are tissue dependent.  Generally, the temperature dependence of T1 can be 
described as  
               ( ) ( ) ( )11 ref refT T T T T Tα= + −                  (2.6) 
where Tref is a reference temperature and α is the temperature sensitivity (dT1/dT).  α has 
been measured in several tissues with difference values including 0.97 %/°C in adipose 
tissue (65) and 1-2 %/°C in soft tissue (63, 64, 66-68).   
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 Although measuring T1 requires a longer imaging time, the change in T1 can be 
shown to be related to the change in signal from spin echo or gradient echo images.  
Generally, the signal, S, can be described as 
1
1
( )
0
( )
1( ) ( )sin
1 cos
TR
T T
TR
T T
eS T M T
e
θ
θ
−
−
−
∝
−
       (2.7) 
where θ is the flip angle.  The signal decreases with increasing temperature due to 
increasing T1 and decreasing M0.  By taking into account the small nonlinear temperature 
dependence of M0, the change in S as a function of temperature can be described as 
1
dS dS S
dT dT T
α= −      (2.8) 
which takes into account both the decrease in M0 and the increase in temperature or vice 
versa.  Therefore, by neglecting the small T2 (or T2* for gradient echo acquisitions) 
temperature dependence and weighting in T1-W images, the change in signal in T1-W 
images as a function of temperature can be described as  
( )
( ) ( )( )
1
2
1 1
1
1 cos 1
1 1 cos
TR
T
TR TR
T T ref
ref
TR edS
SdT TT T e e
α θ
θ
−
− −
−
= − −
− −
   (2.9) 
It is important to note that changes in tissue properties, such as coagulation, can cause 
changes in S which will affect temperature measurements (69). 
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2.2.4 SPIN-SPIN RELAXATION TIME (T2) 
As with T1, there is an increase in T2 relaxation time with increasing temperature.  
In observing the signal from a T2-W image with increasing temperature, there can be a 
large sigmoidal decrease that can even remain during cooling of the tissue (70).  This is 
an important characteristic of irreversible tissue damage which is useful to define the 
outcome of a thermal treatment.   Therefore, although T2 may not be good quantitative 
means to measure temperature changes, it often plays a role in treatment verification in 
high-temperature thermal ablations.   
2.2.5 MAGNETIZATION TRANSFER (MT) 
Generally, MT techniques use spectrally-selective RF pulse to saturate protons 
bound to macromolecules which are normally not visible in MR due to very short T2 or 
T2* values.  During the RF pulse, the bound, saturated protons enter the primary pool of 
water protons or transfer the magnetization to the primary pool (71).  These exchanges 
are temperature dependent.  For example, MT-weighted signals were determined to be 
tissue dependent, with some tissues showing relatively no change in signal such as in 
adipose tissue and brain.  In tissues where a change in signal was seen with temperature, 
effects on MT-W images were nonlinear with either increasing signal (muscle, heart, 
prostate, liver) or decreasing signal (blood)  (72, 73).  These variances in temperature 
sensitivities do not make MT a readily reliable method for MRTI. 
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2.2.6 PROTON RESONANT FREQUENCY (PRF) SHIFT  
2.2.6.1 Physical Basis 
Temperature sensitivity of the PRF was first reported by a group led by Pople in 
1958 (35) and later by Hindman (34).  The temperature dependence in the PRF arises 
from the hydrogen bonding between hydrogen protons and oxygen nuclei in water.  In 
tissue, water is the most abundant compound that contains hydrogen protons.  When 
temperature increases, the increased kinetic energy of the water protons result in a longer 
hydrogen bond with other water molecules and a shorter covalent bond between the 
hydrogen and parent oxygen atoms.  This results in the proton lying in closer proximity to 
the oxygen’s electron cloud, thereby changing the proton’s chemical shift, σ (Figure 2-1).  
The PRF, f, can then be expressed as a function of the chemical shift where 
                                             ( )0 1f Bγ σ= −                   (2.10) 
γ is the gyromagnetic ratio (42.58 MHz/Tesla for hydrogen atoms) and B0 is the applied 
magnetic flux density.  The chemical shift, σ, theoretically is related to the electronic 
structure around the nucleus.  Usually empirical approaches are used to describe the 
chemical shift since theoretical calculation requires extensive knowledge of the electron 
density in the ground and excited states of the molecule as well as the excitation energies.  
Generally, the chemical shift is the contribution of the electrons surrounding the nucleus 
as well as other surrounding molecules around the nucleus (74).    
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Figure 2-1 Illustration of temperature effects on the PRF 
As temperature rises, the hydrogen bonds (green line) between hydrogen and neighboring oxygen atoms 
stretch, bend and break.   This causes the hydrogen to move closer to its own oxygen’s electron cloud 
making it better shielded and changing the chemical shift, σ. 
 
2.2.6.2 Temperature Sensitivity of the PRF 
Measuring the PRF shift as a function of temperature or measuring the distances 
between two spectral peaks to measure temperature has long been used in NMR in the 
field of analytical chemistry. When compared to other MRTI-based parameters, the 
temperature sensitivity coefficient of the water PRF is relatively the same for different 
tissues is close to pure water which has a temperature sensitivity coefficient (TSC) of  
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-0.010 ppm/ºC (34).   Many studies have been performed in vivo to measure the 
temperature sensitivity of the PRF.  McDannold presented a thorough review of the TSC 
of the PRF using both CPD and CSI techniques.  Most TSC values in several tissues have 
been found to be between -0.009 to -0.010 ppm/°C (75).  This corroborates what 
Hindman reported initially in pure water (TSC=-0.01 ppm/°C) (34).   However, some in 
vivo studies have measured values above and below this range.  Peters et al. stated a 
possible reason for the discrepancies is due to the temperature-induced changes in the 
bulk magnetic susceptibility (76).  This can also be affected by the orientation of the heat 
source in relation to the magnetic field.  Electrical conductivity of tissues can also change 
the temperature dependence (77).   
In fatty tissue, De Poorter et al. measured an overall TSC of -0.0097 ppm/°C with 
a susceptibility constant of -0.0013 ppm/°C giving a corrected field shift of -0.0088 
ppm/°C (43).  In a separate study by a different investigator, when using lipid (bulk 
methylene) as an internal reference, the TSC of the difference was measured and found to 
be around -0.00852 ppm/°C (37).   A study using a line scan echo-planar spectroscopic 
imaging (LSEPSI) technique on a mayonnaise and lemon juice phantom also found a 
similar TSC when using bulk methylene as an internal reference (45).  
 Ex vivo tissues have shown little change in sensitivity when compared to in vivo 
tissues (75, 78, 79).  It is also important to note that the sensitivity does not change when 
tissues coagulate, which is in contrast to what is seen in T1-based MRTI (37).  This is 
crucial for safety at high-temperature ablations to be able to measure temperature after 
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damage has occurred to assure temperatures do not reach excessive levels to prevent 
charring of tissue.   
There is also growing interest in trying to use CSI for absolute temperature 
estimations.  Currently, MRTI methods are most often used to measure changes in 
temperature and not absolute temperature.  Absolute temperature estimation is an 
established method in NMR experiments.  For instance, in a sample tube, the shift 
between ethyl (-CH2-CH3) or methyl (-CH3) protons to the hydroxyl (-OH) protons is 
commonly used in the NMR setting.  For MR, the goal is to quantify water, lipid and/or 
metabolite peak locations and their relative differences between water between them to 
make absolute temperature measurements. There have been studies where N-
acetylaspartate and water was used to measure temperature in the brain with low spatial 
and temporal resolution (80, 81).  However, there are many factors that can affect the 
distribution of the metabolite, lipid and water chemical shifts including intravoxel 
temperature variations, pH, magnetic ion concentration, blood-oxygen level dependent 
(BOLD) effect, J-coupling effects and susceptibility (37).  According to a recent review 
of MRTI, the “feasibility of absolute temperature imaging has not yet been established; 
further detailed investigations will be required for that” (37).    This is a highly-desired 
diagnostic imaging capability to detect highly metabolic or inflamed lesions which can be 
at a higher temperature compared to the baseline temperature.   
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2.2.6.3 Complex Phase Difference Techniques for Measuring the PRF 
A fast CPD method (38) has been the preferred method to estimate the PRF shift 
indirectly.  To estimate the temperature change in a voxel, the difference between the 
current phase image, Φ, and the reference image, Φref, can be related to the TSC 
described as 
                                                         
02
refT
B TEπ α γ
Φ−Φ
∆ =
⋅ ⋅ ⋅ ⋅
                                        (2.11) 
where α is the TSC (ppm/°C) and TE is the echo-time (ms).   
In CPD techniques with sufficient SNR (≥5), the uncertainty in the CPD image, 
σ∆φ ,can be expressed as 
          
A
22
A SNRφ
σ
σ ∆ ≅ =                                   (2.12) 
where A is the magnitude signal, σ is the noise of the magnitude signal, which is assumed 
to be approximately Gaussian distributed, and SNRA is the signal-to-noise ratio of the 
magnitude image  (82).  A contrast-to-noise ratio in the phase difference image, CNR∆φ, 
can then be defined by 
                      ( )
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         (2.13) 
assuming a spoiled gradient-echo acquisition.  Note that this is essentially the product of 
the TE (which is proportional to ∆φ) and the SNR.  The dependence of TE on the phase 
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difference constrains the CNR∆φ  to be optimal at TE=T2*, which can be shown by 
differentiation of equation 2.13 (82).   
 A major advantage of the CPD technique for PRF-based thermometry is its high 
spatial and temporal resolution (~1.5x1.5x4 mm3, <5 sec (39)).  Typically, fast 
temperature imaging can be achieved with GRE acquisitions (38) or EPI (83).  As stated 
above, the optimal TE for CNR in CPD is at the T2* of the tissue.  As a result, standard 
GRE acquisitions have a relatively long TR which lowers spatial and temporal resolution.  
If higher resolutions are needed, echo shifts are applied with TR<TE at an expense of 
SNR (41).  Alternatively, the use of EPI allows for longer TEs without sacrificing 
resolution or SNR.  Techniques using balanced steady-state free-precession (bSSFP) have 
also been studied for PRF-based temperature mapping.  This is accomplished by 
measuring a linear fit along several TEs acquired.  However, the phase behavior was 
found to be highly nonlinear with this technique so simple phase to frequency mapping is 
not feasible (48).   
 Although CPD techniques are advantageous when high spatial and temporal 
resolution is required, there are several well-known limitations of this technique.  
Intravoxel lipid contamination (40, 41), inter- and intra-scan motion (42), tissue 
susceptibility changes (43) and static magnetic field drifts (44) all cause artifacts that are 
commonly encountered with CPD techniques.    
It is important to remember that the PRF shift is a function of temperature due 
primarily to changes in the hydrogen bonds between water molecules.  These hydrogen 
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bonds are absent for protons in lipid molecules, which are covalently bonded.  Therefore, 
the temperature sensitivity of lipid tissue is a stronger function of the macroscopic 
susceptibility.  The presence of lipid can alter the phase in CPD acquisitions which, in 
turn, can affect temperature estimates.  Common practice to address this is to simply 
suppress the lipid signal (40, 41).  Although lipid signal is suppressed, however, it does 
not correct susceptibility effects that lipid can have on the nearby water molecules.  The 
effect of a mixed water and lipid environment cannot be handled completely with 
suppression because lipid is still physically present in the tissue and can have an effect on 
temperature estimation in the voxel via susceptibility effects.   
 As with most imaging techniques, intra-scan and inter-scan motion is another 
common issue that must be addressed with CPD approaches.  Intra-scan motion is motion 
during the acquisition which results in view to view k-space errors seen as image blurring 
and ghosting.  Imaging times can be decreased to reduce intra-scan motion but at an 
expense of SNR.  Inter-scan motion is a more difficult problem to handle since images 
are subtracted to obtain temperature estimates.  It is important to note that motion not 
only effects the spatial registration between scans but also the magnetic field which 
changes the phase leading to errors in temperature estimation (33).   Multiple strategies 
have been developed in an effort to overcome artifacts from inter-scan motion.  For 
respiratory motion, gating with mechanical respiration has been successful but this, of 
course, is invasive (84).   Gating with free-breathing has been used but it is challenging 
when there is irregular breathing (85).  The use of navigator echoes has also been studied 
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as well as referenceless thermometry which estimates the background phase in the treated 
area by fitting a polynomial extrapolated from unheated regions (86).  These studies have 
had limited success but according to a recent review of MRTI, “motion is the most 
prevalent problem for temperature monitoring with PRF phase mapping (CPD) and the 
main reason that has impeded its acceptance for clinical applications in areas that are 
subject to motion” (33).   
 Macroscopic susceptibility changes in tissue can also affect the accuracy of 
temperature estimates with the CPD technique (43).  Susceptibility does change with 
temperature, but when compared to the PRF as a function of temperature, this effect is 
four to five times smaller in magnitude.  It has been approximated as being linear with 
0.0026 ppm/°C for pure water and 0.0016 ppm/°C in muscle (43).  It has been found 
though that the temperature dependence of the susceptibility is tissue-dependent (87) as 
well as the orientation and geometry of the heating source (76).  One possible method to 
correct for susceptibility effects is to measure the PRF response to temperature in a 
chemical specimen that is not sensitive to temperature changes.  Lipid is such a specimen.  
It is expected that lipid will experience susceptibility effects in the voxel.  Therefore, 
using lipid, or any covalently-bonded proton, as an internal reference to correct for 
susceptibility is a possible means to improve temperature measurements (37).   
 Field drift is yet another effect that must be considered when the PRF is used for 
MRTI.  Temporal drifts in the local magnetic field due to increased gradient duty cycles 
and eddy currents can change the PRF (88).  Simple corrections are often possible by 
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using a reference phantom at a fixed temperature (44).  More elaborate corrections are 
also possible using multiple reference phantoms to estimate the linear shifts across the 
image (89).  A method that calculates the apparent diffusion coefficient (ADC) and PRF 
has also been proposed to correct for field drift (90).  As with susceptibility, lipid or 
another internal covalently-bonded proton reference can be used to aid in correcting for 
field drifts (37).   
2.2.6.4  Chemical Shift Imaging Techniques for Measuring the PRF 
An alternative to the indirect CPD method is a direct method of measuring PRF 
shift via chemical shift imaging (CSI) techniques (45-48).  CSI has several advantages 
over CPD techniques.  One is that the water proton resonant frequency is measured 
separately from other resonances whereas CPD measures the mixture of frequency 
components in each voxel resulting in a variable response.  This immediately relieves the 
problem of intravoxel lipid contamination seen in CPD.  Also, the lipid signal can be 
used as an internal reference to account for field drifts, susceptibility and motion since it 
is relatively insensitive to temperature (37). Therefore, CSI would be particularly useful 
in areas with high lipid content, such as bone marrow, breast, and head and neck lesions 
(45).  In addition, it may be useful in patients with fatty-liver for minimally-invasive 
treatments of liver lesions (91).  It is also important to note that areas with little or no 
lipid can also benefit from CSI-based temperature imaging since directly measuring the 
water PRF can potentially result in higher sensitivity given appropriate SNR with 
adequate spectral analysis techniques (45, 53).  Therefore, researchers have worked to 
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develop CSI techniques that increase the sensitivity and spatiotemporal resolution while 
maintaining the ability to reduce artifacts seen in CPD.  However, as mentioned in the 
previous chapter, these studies have limitations for multiple reasons.    
Magnetic resonance spectroscopic imaging (MRSI) was proposed for MRTI 
before the CPD technique was introduced (46).  However, the acquisition time needed for 
the desired spectral resolution (with or without suppression) was deemed impracticable 
for MRTI.  For example, MRSI measurements using a small 32 x 32 matrix with a 
spectral bandwidth of 10 ppm at 1.5T and a spectral resolution of 0.01 ppm (1 °C) 
required 26 minutes per acquisition.   
One approach to overcoming some of the time limitations of the MRSI approach 
is to use echo planar spectroscopic imaging (EPSI) techniques.  These techniques have 
been proposed for temperature monitoring and prior studies have demonstrated that 
temperature changes can successfully be monitored, lipid can be used as an internal 
reference when present, and artifacts due to motion can be reduced (47).  Although this 
method was demonstrated to be considerably faster than conventional MRSI, initial EPSI 
acquisitions still required 3 minutes to acquire a low spatial resolution temperature image 
(5 x 5 mm2) on a 3.0T system.  This is because the technique used 4 interleaved shots of 
16 echoes (5.2 ms echo-spacing, total of 64 echoes) to achieve an effective echo-spacing 
of 1.3 ms to avoid aliasing of the lipid signal due to a narrow spectral bandwidth.  Data 
interleaving resulted in a spectral bandwidth of 769 Hz (12.04 ppm) with a spectral 
resolution of 12.0 Hz (0.188 ppm).  In addition, spectra from the EPSI technique can be 
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degraded by instability in the magnetic field and motion during the phase-encoding 
process of the acquisition (37). 
McDannold, et al. applied a line scan EPSI (LSEPSI) technique (92) to address 
limitations to previous CSI-based MRTI techniques (45, 93).  LSEPSI is a combination 
of EPSI with a voxel-selective technique for column scanning (92).  This method 
substantially improved the spatial and temporal resolution.  Specifically, in an in vivo 
breast scan at 1.5T, a 32 x 32 cm2 FOV was acquired in 4.2 seconds with a spatial 
resolution of 5 x 5 x 5 mm3.  However, this spatial resolution is still considered quite 
poor compared to CPD methods (39).  Thirty two echoes where acquired with a high 
receiver bandwidth of ±64 kHz, which limited the SNR.   
As stated in chapter 1, major contributors to the low spatiotemporal resolution in 
these studies include interleaved echo trains and high receiver bandwidths to decrease the 
echo-spacing to avoid aliasing of the lipid peak.  In addition, high ETLs were used in 
Fourier-based approaches to calculate the PRF.  The high ETL degrades the 
spatiotemporal resolution.  In the next chapter, we present an approach that will allow 
spectral aliasing of lipid peaks to negate the need of interleaving echo trains and allow 
reduced bandwidths for higher SNR. To further aid in increasing spatiotemporal 
resolution and sensitivity, a model-based approach to calculate the PRF using 
undersampled data will be presented.  The combination of these acquisition and post-
processing techniques will be used to test our hypothesis.  
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Chapter 3: Theoretical Background for Dynamic 
Chemical Shift Imaging  
3.1 Introduction 
In this chapter, the theory and background of the acquisition strategy, spectral 
processing, and mapping are presented.  First, gradient-echo imaging will be introduced 
along with details of the acquisition implementation for rapid CSI.   Next, spectral 
processing of CSI data will be overviewed.  In this context, the detailed theory of 
autoregressive moving average (ARMA) modeling will be presented.  Finally, details will 
be outlined on how these spectral parameters, specifically the PRF for temperature 
imaging, are mapped to images using a k-means clustering algorithm.  
3.2 Rapid CSI from a Multi-Gradient Echo Acquisition:  From 
Theory to Implementation 
Fundamentally, several conditions must be met in order to image the spatial 
distribution of hydrogen protons for MRTI.  A strong magnetic field, B0, is needed in 
order to align a small majority of protons with the field.  Radiofrequency (RF) pulses at 
the resonance frequency, ω, are used to tip the spin population.  As the population relaxes 
back to equilibrium with the magnetic field, a small voltage is measured in an RF-tuned 
receiver coil which is perpendicular to B0.   
In the laboratory frame of reference in the absence of gradients and relaxation 
effects, the signal from a 3D spin system, ρ(x,y,z), in a given volume, V, can be described 
as  
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To spatially localize the signal, gradients are used that spatially vary the magnetic field 
over the sample.  
For an acquisition in the axial plane, the z-direction is assigned as the slice-
selection direction.  A gradient is applied in this direction in conjunction with the 
bandwidth-limited RF excitation pulse.  This creates a planar distribution of spins 
described by 
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where z0 is the center of the slice and ∆z is the slice thickness.  The z-dependence in ω 
can be related to the magnetic field, B0, and the slice encoding gradient, Gz, where 
0( )z zB G zω γ= +      (3.3) 
After the RF pulse, the spins in I can be localized spatially using gradients and encoded 
in k-space.  The relationship between a location in k-space at time, t, and the gradients in 
the x and y directions is given by 
0
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t
k t G dγ τ τ= ∫      (3.4) 
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In the collection of data in k-space, a phase encoding gradient moves collection of data to 
one line in k-space.  This is followed by a frequency encoding gradient that is applied 
during the signal readout.    
 Mathematically, the signal at a location in k-space, S(kx,ky) can be given by 
dydxeeyxkkS yx kiykixyx ∫∫
−−∝ ππρ 22),(),(    (3.5) 
It is important to note that this equation gives the spatial frequency domain of the spin 
distribution and a 2D Fourier transform can be used to represent the data in the spatial 
domain (74).   
 Figure 3-1 displays the pulse sequence diagram for a fast gradient echo 
acquisition typically used for standard CPD MRTI.  A small flip angle RF pulse is used 
during encoding of the slice selection gradient, Gz.  The polarity of Gz is then switched to 
account for de-phasing of the transverse magnetization.   The frequency encoding 
gradient, Gx, is turned on to move across k-space.  Gy is then applied for the phase 
encoding before the positive gradient of Gx encodes the signal.  A Gz gradient is then 
applied to dephase residual transverse magnetization.  
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Figure 3-1 Pulse sequence diagram for a fast gradient-recalled echo (FGRE) acquisition 
This represents a balanced pulse and gradient schematic for a high spatiotemporal CPD acquisition.  Note 
that one echo is collected per TR.   
In this research, the fast gradient-recalled echo (FGRE) acquisition was modified 
to provide multiple echoes per TR for encoding the chemical shift (Fig. 3-2). As with 
FGRE, the sequence is compatible with parallel acquisition techniques, such as SENSE, 
to increase the speed of acquisition (94) and can acquire images in interleaved slice 
acquisition mode or in a sequential slice acquisition mode with RF spoiling to cancel out 
any residual transverse magnetization before the next TR period by modulating the phase 
between successive RF pulses.  Note that the TR is kept constant so there is no loss in 
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spatiotemporal resolution compared to CPD from a FGRE acquisition.  The ETL and ESP 
are set in order to collect the selected number of echoes within the TR.   
 
Figure 3-2 Pulse sequence diagram of a 2D unipolar MGE acquisition 
The phase encoding gradient only pulses once per echo train.  The frequency-encoding gradient can be 
implemented in bipolar or unipolar mode.  In the unipolar sequence shown above, when each echo is 
acquired in a positive gradient readout, the free induction decay (FID) is sampled.   
 
The sequence can be run using unipolar readout gradients with time-optimized 
rewinder (i.e. flyback) gradients as shown in Figure 3-2 or using bipolar readout 
gradients.  In bipolar gradient mode, negative polarity readout data is time reversed in k-
space prior to image reconstruction by Fourier transformation.  Also in bipolar gradient 
mode, N/2 spectral ghosting caused by timing errors between the positive and negative 
readouts can be corrected by applying a calculated linear phase shift to the images 
reconstructed from every other echo time (95).  The moments of the signal are calculated 
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in k-space.  The phase shift is measured by the differences in the moment between odd 
and even echoes in the bipolar readout (Figue 3-3).   
 
Figure 3-3 Differences between bipolar and unipolar readout gradients with N/2 correction  
Bipolar and unipolar readout acquisitions were performed on an agar phantom.  Due to timing errors 
between odd and even echoes, the bipolar readout gradient is susceptible to N/2 ghosts (top left).  These 
timing errors can be corrected by calculating the phase change in k-space (top right).  Unipolar readout 
gradients are immune to these errors but using unipolar gradients comes at an expense of larger ESP and 
lower SNR (96).     
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We made two fundamental changes in the conventional acquisition strategy for 
fast CSI acquisitions.  First, the echo-spacing (ESP) parameter was increased in order to 
facilitate use of lower readout bandwidths to provide higher SNR.  In the case of previous 
3.0T CSI acquisitions, restraints on the ESP have usually resulted in the use of multiple 
interleaved echo-trains in order to avoid aliasing (47).  Because of the relaxed ESP 
associated with this technique we can acquire multiple echoes within one TR acquisition 
thus increasing the spatial and temporal resolution compared to previous CSI acquisitions 
for MRTI.  This causes aliasing of the lipid peak.  However, in MRTI we are only 
interested in the change in the lipid PRF and not the absolute position when measuring 
temperature changes.   
The second modification was to collect only the number of echoes that would fit 
into the TR period of our standard CPD MRTI sequence.  The artifacts associated with 
this undersampling required innovative processing in order to resolve the lipid signal as 
outlined in the following section. 
To increase sensitivity, uncertainties in the PRF as a function of acquisition 
parameters need to be determined.  It is important to note that in PRF mapping, the 
frequency difference, which is directly proportional to temperature, is not constrained to 
TE=T2*, in contrast to CPD.  For an homogenous voxel, 
                               ( )
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which means that the sensitivity of measuring frequency changes is directly proportional 
to the SNR of the source image from a gradient echo acquisition.  This gives an image 
metric where the sensitivity of the frequency changes can be measured and verified using 
the spectral analysis technique as described in the next section.   
3.3 Spectral Processing of CSI Data  
In many 2D, high spectral resolution, low spatiotemporal resolution CSI 
techniques, several chemical shifts including water, lipid, and metabolites such as choline 
and N-acetyl aspartate (NAA) are mapped by adding a spectral dimension to the k-space 
data to encode chemical shifts.  For example, EPI gradients allow signal readouts which 
encodes one spatial dimension and the spectral dimension at the same time.  In 1983, Sir 
Peter Mansfield, Nobel Laureate in Medicine for the development of MR, proposed EPI 
for 2D CSI with a hybrid projection reconstruction method to bypass Fourier transforms, 
which were slower computationally at that time (97).   
Several studies have been done to build on what was proposed by Mansfield.  
Initial implementations suffered from poor gradient performance and artifacts arose from 
the convolution of spectral and spatial information.  Posse et al. improved this by 
improving the orthogonalization of the spectral and spatial information to reduce artifacts 
seen in 2D CSI (98).  Rapid acquisition and relaxation enhancement (RARE) (92, 99, 
100) and LSEPSI (101) have also been investigated to improve the spatial, temporal and 
spectral resolution for spectroscopic inquiry.  Parallel imaging (102, 103) and 
compressed sensing (104, 105) techniques have also been implemented to improve the 
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spatiotemporal resolution of these otherwise low spatiotemporal, high spectral resolution 
CSI techniques.   
There are several methods to quantify spectra in various domains, including the 
frequency domain, time domain and z-domain.  Originally, MR signals were calculated 
using continuous wave (CW) spectroscopy.  These spectra were recorded by scanning the 
frequency axis, which measured the intensity of the signal as a function of frequency 
(106).  Currently, MR spectra are obtained in the time domain with post-processing 
typically by deconvolution of the resonance frequencies into the frequency domain via 
Fourier transformation.  The time-domain acquisition reduces scan time and increases 
SNR compared to CW spectroscopy (107).    
The Fourier transform (FT) is the most common method to measure MR spectra 
by transforming the MR signal from the time domain to the frequency domain.  
Generally, the transform can be represented as  
∫
∞
∞−
−= dtetfF tiωπω 2)()(        (3.7) 
where ω is the frequency, t is time, and f(t) is the time-domain function.  The FT is 
bijective and invertible meaning that the signal can be measured in one domain and 
transformed to another.  Although the FT is commonly used, assumptions in Fourier 
analysis impose restrictions on the quality of the spectra.  In a discrete signal, the FT can 
be represented as  
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where An is the discrete representation of the spectra from the time domain signal ak.  As  
seen in this equation, the spectra is dependent on the number of samples N.  The spectral 
resolution is inversely proportional to N (108).  In rapid CSI for temperature imaging, N 
needs to be relatively small to maintain high spatial and temporal resolutions.  By using 
the FT, this comes at a cost of degraded spectral resolution to measure changes in the 
PRF (Fig. 3-3).  In addition, if the data in the time domain has non-zero values at the end 
of the acquisition, this causes apodization of the spectra, which can degrade peaks, 
especially secondary peaks such as lipid.   
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Figure 3-4 The effects of the number of samples on spectra using FFT 
The spectral resolution is directly proportional to the number of samples in the signal.  In this case, the lipid 
peak is more difficult to discern with a lower number of samples.  Spectral resolution can be improved by 
collecting more samples.  This typically comes at a tradeoff of decreasing spatiotemporal resolution. 
It is important to note that the FT doesn’t make assumptions in the model that 
describes the data (see equation 3.6).  The only constraints on the signal is that the 
integral of ( )f t  from -∞ to ∞ exists and that any discontinuities in f(t) are finite (108).  
Although this makes FT useful for a variety of applications, it has a disadvantage of not 
incorporating prior knowledge of the signal.   In addition, the FT is assumed as a single 
sum, where in practice the signal has signal and noise components (50).   
 Several time-domain methods have been developed to analyze spectra.  The main 
goal of these methods is to minimize the differences between the measured data and the 
signal model through a non-linear least squares problem.  This depends on the particular 
algorithm being able to find a global minimum in the data and avoid errors from finding 
local minima.  Generally, the risk of not finding the optimal solution using these methods 
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increases when initial conditions are away from what is acquired in the signal.  This often 
requires heavy user interaction in order to manually obtain starting values for these 
algorithms (109).  Interactive algorithms such as variable projection (VARPRO) (110) 
and the advanced method for accurate, robust and efficient spectral fitting (AMARES) 
(111) are common MR quantification tools.  VARPRO uses the Levenberg-Marquadt 
(LM) algorithm (112), which was later replaced by AMARES when reviewers cited 
greater flexibility.  Baseline errors can also be handled with time-domain methods with 
user interaction (109).   
 Visualization of spectra and fitting results are best shown in the frequency domain 
(113).  Compared to time-domain methods, frequency-domain methods have fewer model 
parameters that need to be fitted.  In this domain, methods can be separated as non-
iterative and iterative methods.   The most widely used quantitative method in this 
domain is frequency-selective area under the peaks.  However, with this method it is 
difficult to discern overlapping peaks and high baseline signals.  Additionally, low SNR 
can degrade the ability for quantification (113).  Singular value decomposition (SVD) 
methods have also been developed, where only regions along a specific frequency are 
used for analysis, resulting in faster processing times (114).  In iterative processes, non-
linear least squares techniques via algorithms such as the LM algorithm (112) have been 
used.  Specifically, with the LM algorithm deGraaf and Bovee used the algorithm to 
obtain in vivo proton spectra in the brain using prior knowledge of metabolites from in 
vitro metabolite solutions (115).  In addition, mixed Lorrentzian-Gaussian (or Voight) 
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models were developed to fit the signal in the frequency domain.  In both time and 
frequency domain, algorithms are shown to be computationally expensive and/or requires 
a priori knowledge of the spectra (116).    
There are also “black-box” techniques where little interaction is needed from the 
user which makes it attractive for rapid temperature imaging (50).  These methods use the 
z-transform where 
∑∑
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 and δ is the Kronecker delta function.  Although these methods are commonly 
characterized as time-domain methods, it is important to note that analysis is performed 
in the z-domain where the frequency-domain is a subspace where 1)}({ =tfZ .  
Theoretically, in a MR signal containing water and lipid, x(t), can be represented 
discretely as a sum of damped complex exponentials convoluted with a comb function, 
that is,  
                                                                                                                                  
(3.10) 
where CW,L is the complex amplitude for water (W) and lipid (L), respectfully,  fW,L is 
PRF, T2W,L* is the apparent spin-spin relaxation time, TE is the echo time and n is the 
number of echoes.  By taking the z-transform, equation 3.10 can be represented as 
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(3.11) 
Equation 3.11 can be rewritten as 
                                                                                                                                   (3.12) 
Note that this can also be represented as a geometric series where 
                                                                                                                                     (3.13)           
(49).  Therefore, the poles of X(z) can provide the frequency and T2* information for 
water and lipid.  The complex amplitude of each exponential can be calculated using the 
residue evaluated at each pole  (51, 52).  In general, equation 3.13 in the presence of 
noise can be expressed as an autoregressive moving average (ARMA) process described 
as 
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Finding the coefficients, αn and βn, involves solving a set of overdetermined equations.  
One method to approximate the coefficients was proposed by Belkic using the Pade’ 
approximant (PA) based on a technique originally developed by Henri Pade’ (51, 117, 
118).   While the PA is able to process low TE signals and expand to non-Lorentzian 
spectra, it has limitations at low SNR.  In addition, the PA demonstrates low performance 
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with a low number of poles and zeros, especially if it less than the number of samples 
(119).     
Another analysis method is to use an iterative method which will potentially 
converge to a more accurate and precise solution compared to analytical methods (120).  
Thus, we propose a hybrid approach using Prony’s method (120) and the iterative 
Steiglitz-McBride (SM) algorithm (121).  Both algorithms are used in applications such 
as digital filter design and communications and a detailed treatment of both algorithms 
can be found in (120).  The reasoning to use these algorithms include the minimal 
interaction required by the user (50), relatively rapid processing time compared to non-
linear least squares methods (53), and performance in the presence of noise (121, 122).   
Here the algorithms will be explained to show how these can be used to calculate the 
coefficients and provide frequency, T2* and amplitude content for water and lipid.  
 Equation 3.14 can be represented as  
( ) ( ) ( )b t h t a t= ∗                                                     (3.15) 
since, as in Fourier theory, the convolution in the time-domain is a product in the z-
domain.  In matrix form, equation 3.15 is 
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(3.16) 
 
where N is number of chemical species and K is the number of echoes, and  xn are the 
samples in the time-domain.  In Prony’s method, h(t) is partitioned and an error term, e, is 
added where  
(3.17)                                                                                                                                      
 
H1 contains N-1 rows, H2 is a column vector with K-N-1 terms, H3 is the remaining (K-N-
1) x N matrix and α* is simply a column vector of the denominator coefficients.  This 
separates the interdependence of α and β terms in order to find the solution.  First, the α 
terms are found by taking the pseudo-inverse to minimize e, that is, 
( ) ( )1 #3 3 3 2 3 2* t tH H H H H Hα
−
= − = −                                    (3.18) 
where t is the transpose operator and # denotes the pseudo-inverse operation.  Once α* is 
calculated, β can be simply calculated by  
1Hβ α=      (3.19) 
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 Unlike Prony’s method, which works by minimizing the error in the 
overdetermined set of equations, the SM algorithm seeks to iteratively minimize the error 
between a model estimate (xd) and the measured signal (x).  The algorithm uses an initial 
estimate (from Prony’s method) and quickly iterates to a solution.  Briefly, the algorithm 
takes the first N columns of the matrix 
 iH Hα α= ⋅      (3.20) 
 where H is the K x K-N+1 matrix as described in equation 3.16 and α is the initial 
estimate.  This partitioned matrix is denoted as Hα′ .  Knowing that   
1d i i ix x e H H H eα αα β+ ′= + = = +    (3.21) 
As in equation 3.18 the error term, e¸ can be minimized where  
( )#1i i iH H Hα αα β+ ′=      (3.22) 
and 
( )# dH xαβ ′=       (3.23) 
Therefore, combining equations 3.22 and 3.23 gives  
( ) ( )# #1i i i i dH H H H xα α αα + ′ ′=      (3.24) 
which provides an iterative solution.  Once α is known, β can be calculated again by 
using equation 3.19.   
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 Once coefficients, α and β, are known, the poles can be calculated as roots of the 
denominator in equation 3.14.  If ρ1 and ρ2 denote the poles for water and lipid, 
respectively, then the PRF of water or lipid (in ppm) can be expressed as   
1,2
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     (3.25) 
where ∆t is the time between echoes, γ is the gyromagnetic ratio and B0 is the applied 
magnetic flux density.  In addition, the T2* value of water or lipid can be expressed as 
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Finally, the complex amplitude of water and lipid can be computed separately using 
where 
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3.4 CSI Mapping using the k-means Algorithm 
An important area of research in MR currently is the mapping of MR-detectable 
nuclei with different chemical shifts.  The techniques for accomplishing this range from 
mapping multiple metabolites which is commonly used in various sites including brain, 
prostate and breast (123) to several techniques that are used to separate lipid-based 
chemical shifts from images to avoid obscuring underlying pathologies.   This is a multi-
faceted problem that involves not only separation of chemical shifts spectrally but also 
accurately mapping these parameters into images.  The accurate mapping of chemical 
shifts is necessary in MRTI so appropriate temperature sensitivity coefficients can be 
applied to measure temperature (i.e. water must correctly be identified in order to 
measure temperature changes and lipid must be indentified accurately to use as an 
internal reference).  
Essentially clinical CSI data for metabolic inquiry are currently processed by 3D 
FFT with filtering and/or zero-filling of the k-space data or by spectral modeling.  For 
example, one method used exponential line broadening, Fermi filtering in the spatial 
domains to reduce truncation, and water suppression through low-pass filtering of the 
spectra in the time-domain (98).  In addition to the processing of the spectral data, special 
consideration is needed for mapping the chemical shifts spatially.  For instance, 
corrections are needed for field inhomogeneities and gradient eddy currents.  Typically, 
data with unsuppressed water signal is acquired in order to calculate the field map to 
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correct for field inhomogeneities.  The water signal can also be used to scale the relative 
concentration of other chemical shifts. 
In CSI techniques for lipid and water separation, acquisitions and mapping 
strategies are different since a limited number of chemical shifts are known a priori.  The 
motivation to separate the chemical shifts in lipid-water imaging is that the low T1 of 
lipid makes it bright on many clinical imaging protocols.  This can hide underlying 
processes such as contrast-enhancement of tumors, edema, and inflammation.  There is 
also interest in knowing the lipid content in organs such as liver as well as using lipid 
images to distinguish certain tumors such as lipomas.  There are multiple techniques to 
either remove lipid from the images or create “water-only” or “lipid-only” images.   
One of the first techniques introduced to remove lipid from images is a chemical 
shift selective (CHESS) acquisition (124).  In these acquisitions, a saturation pulse is 
centered at the dominant lipid peak frequency and the pulse flips the lipid protons 90° 
into the transverse plane.  The RF pulse is immediately followed by a crusher gradient to 
spoil the transverse magnetization of lipid.  The imaging acquisition is then acquired 
leaving little time for lipid to recover longitudinal magnetization thus suppressing the 
lipid signal in the image.  However, this technique is sensitive to inhomogeneities in the 
static magnetic field and in the RF pulse (B1), which can either leave lipid unsuppressed 
or suppress water. 
Another method is to selectively excite the water instead of suppressing the water 
peak.  These methods can excite protons in a particular spatial or spectral region.   The 
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basic mechanism for these methods is to use RF pulses at specific intervals where lipid 
magnetization is flipped onto the longitudinal axis while signal is collected from the 
flipped water protons.  As in CHESS sequences, these acquisitions are sensitive to field 
inhomogeneities.  The use of multiple pulses can also require longer TRs which will 
increase imaging time.  Unlike CHESS, it is relatively insensitive to inhomogeneities in 
B1 (125).    
Short TI inversion recovery (STIR) (126) is yet another method to suppress lipid 
to visualize underlying pathologies.  This method takes advantage that non-enhancing 
tissue containing water has a longer T1 than lipid.  An inversion pulse is implemented 
followed by a time interval (TI) allowing the lipid magnetization to relax to the transverse 
plane.  Then an imaging acquisition is implemented, albeit with lower water SNR.  An 
advantage is that it is insensitive to field inhomogeneities and therefore it can be used in 
large or off-centered FOV situations.   
Instead of selectively suppressing or exciting chemical shifts, there is a class of 
techniques based on the phase behavior between water and lipid.  An early approach to 
phase-sensitive lipid-water separation was developed by Dixon (127) and thereby the 
techniques are commonly termed “Dixon Methods.”  By assuming a constant PRF 
difference between water and lipid, Dixon proposed that collecting images at two specific 
TEs can create images where lipid and water are in-phase and out-of-phase.  By adding or 
subtracting these images, “water-only” or “lipid-only” images could be created.   This is 
called a “two-point Dixon method.”  However, this method is sensitive to B0 
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inhomogeneities.  To address this, Glover (128) modified Dixon’s method to obtain three 
echoes at specific TEs where the phase shifts between lipid and water were 0, π, and –π.  
By using phase-unwrapping algorithms, field inhomogeneities can be removed.  Both 
methods, by Dixon and Glover, are insensitive to B1 inhomogeneities and can be used in 
a variety of sequences including fast spin echo (FSE), GRE, and steady-state free 
precession (SSFP) (129).    
Several methods have also been developed to improve on these early Dixon 
methods.  It was noted that three-echo Dixon techniques were redundant and that 
methods are available to acquire field mapping with two echoes (130, 131).  It was also 
shown that lipid suppression is possible with one echo at variable TEs (132).  One 
method by Xiang used a region-growing algorithm instead of phase-unwrapping in 
conjunction with an asymmetric TE acquisition with an analytical solution for water and 
amplitudes (133).  In addition, Ma et al. introduced a FSE method with phase-sensitive 
partial Fourier reconstruction in addition to a rapid two-point FSE acquisition using 
interleaved images (134).   Ma also created a phase correction, region-growing algorithm 
that relies on the spatial gradient of the phase (135).  In this algorithm, the direction of 
the phase is calculated by the magnitude and phase of surrounding voxels.  Recently, 
Dixon methods were used in conjunction with diffusion-weighted imaging for whole-
body detection of cancer metastasis (136).  Iterative decomposition of water and lipid 
with echo asymmetry and least squares estimation (IDEAL) is another phase-sensitive 
lipid-water separation technique that uses a least-squares approach of the multi-echo data 
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to calculate the amplitudes of water and lipid (137).  By assuming equivalency of the 
water and lipid T2*, T2* estimates have been made with IDEAL (138).  In addition, 
multiple peaks of lipid have been mapped given the a priori information of the PRFs and 
amplitudes via calibration (139). 
In each of these CSI techniques, certain assumptions are made in order to 
constrain the model to approximate a certain parameter.  For example, the chemical shift 
between water and lipid in these methods are assumed to be relatively constant.  In the 
presence of temperature changes, this is not the case.  This assumption is made in order to 
accurately approximate another parameter which is most often the relative magnitude of 
each chemical shift. 
As shown above, the PRF, T2* and amplitude of multiple peaks are calculated 
without making assumptions such as a constant PRF shift between water and lipid or 
equivalent T2* in water and lipid.  Here we present a k-means clustering algorithm to 
identify these peaks and reconstruct these parameters into images with water-only and 
lipid-only field maps, T2* maps and T1-W imaging.  K-means clustering and other 
clustering algorithms such as the fuzzy c-means algorithm are powerful techniques that 
have been used to segment MR data typically from standard imaging techniques such as 
apparent diffusion coefficient (ADC), T1, T2, and PD-weighted images as well as 
functional MR data (140-143).  In this work, we investigate how this algorithm can take 
the multi-parametric data to segment and map different chemical shifts such as lipid and 
water without relying on assumptions made in many CSI techniques.  With proper 
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mapping, temperature changes can be accurately measured along with providing multi-
parametric visualization of the spectral data. 
The k-means algorithm is an automated and computationally rapid clustering 
algorithm that was first proposed by Lloyd in 1957 although he did not publish his work 
until 1982 (144).  The term “k-means” was first coined by MacQueen in 1967 (145).  It 
has a variety of applications in machine learning and statistics to partition data based on 
defined variables.   
Given a set of measurements (x1, x2, …, xn) where each measurement is a D-
dimensional real vector, the k-means algorithm partitions the n observations into k 
clusters given that k<n by minimizing an objective function, S, where   
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and ji cx − is the Euclidean distance between data point, xi, and it’s cluster centroid, cj.   
 First, random k clusters are assigned to all n observations and centroids are 
calculated for each cluster.  Data points are then assigned to the nearest centroid.  Every 
data point assigned to a certain centroid is assigned to the same cluster.  Then, new 
centroids are calculated from the new clusters.  This process continues iteratively until 
the centroid calculation converges for each centroid such that cj=cj-1.  Figure 3-4 shows 
graphically in two dimensions the functions of the algorithm.  All spectral processing and 
mapping was implemented using MATLAB (MathWorks, Natick, MA). 
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Figure 3-5 Schematic of the K-means algorithm 
The algorithm assigns random clusters from the observations and centroids are calculated for each k 
cluster.  Observations are then assigned to the nearest centroid.  Then, new centroids are calculated from 
the new clusters.  This process continues iteratively until the centroid calculation converges by for each 
centroid. 
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Chapter 4: Spectral Parameter Estimation and 
Acquisition Parameter Analysis from a 
Rapid Multi-Gradient Echo Acquisition 
4.1 Introduction 
This chapter thoroughly reports the results on the spectral processing and 
acquisition parameters that are needed for accurate and precise temperature imaging.  
First, spectral processing via a filtered Fourier method will be tested, which will outline 
limitations in Fourier-based techniques for measuring spectra with a low number of 
samples.  Next, results from experiments testing the ARMA model as described in 
section 3.3 will be presented (specific aim 1).  The measurements from the ARMA 
model will be used to find suitable acquisition parameters for accurate and precise 
temperature imaging (specific aim 2).  At the end of this chapter, there is a discussion to 
place these results in context for temperature imaging. 
4.2 Spectral Analysis using Fourier Windowing 
4.2.1 MATERIALS AND METHODS 
We investigated the assumption that, with careful selection of spectral filters, a 
windowed FFT technique could possibly provide accurate water and aliased lipid peak 
locations.   A simulated signal containing water and lipid at physiologically relevant 
frequencies was generated.  The amplitude of the lipid component was set to be one-tenth 
the amplitude of water.  For temperature monitoring using lipid, it was assumed that the 
optimal location of the aliased lipid peak would be equidistant from the resonant water 
peak and its N/2 spectral ghost to minimize contamination of the lipid peak from water 
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sidelobes.  The relation between the echo-spacing and the frequency difference between 
water and lipid was analytically determined. 
In addition, we used the Lorentz-Gauss transform which increases spectral SNR 
and resolution by combining a Gaussian window and a positive exponential filter (146).  
The Gaussian window, g(n), is defined as 
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                                        (4.1) 
where N is the total number of samples and σ is the ratio of the length between the two 
points of inflection on the Gaussian to the length of the entire window.   To find a 
suitable σ for this window, the frequencies and amplitudes of the lipid and water peaks as 
well as the sidelobes were measured at different σ values.  The optimal setting would be a 
standard deviation that produces the lowest error in water and lipid frequency estimation 
in simulation.   
To increase spectral SNR for the FFT approach, a positive exponential filter, 
exp(n/T2*), was used where the apparent spin-spin relaxation (T2*) can be quickly 
estimated.  Using simulation, the frequencies and magnitudes of the peaks were recorded 
with and without this filter using the T2* of water-only, lipid-only and a calculated T2* of 
the signal.      
The product of both windows and the signal was zero-filled and Fourier 
transformed to create the simulated spectrum.  The location of the maximum value of 
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each peak was calculated along with a moment calculation around each peak.  These 
values were compared to a Gaussian fit of the peaks as done by McDannold et al (45) and 
also to frequency estimates from the Steightliz-McBride (SM) algorithm which is 
described in the following section.  The time to calculate each spectrum using the 
windowed Fourier method as well as the SM algorithm and Gaussian fitting of the peaks 
were also recorded. 
4.2.2 RESULTS 
The relative distance of the lipid peak from the water peak and the N/2 ghosts at 
physiologically relevant frequency differences were simulated to help determine the best 
echo-spacing (ESP) for the acquisition prior to obtaining experimental data.  By 
assuming that the lipid peak needs to be equidistant from the water and N/2 peaks at 
different frequencies, the optimal ESP was determined to be: 
                         
0
3
4 w l
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Bδ γ−
=     (4.2) 
where w lδ −  is the frequency difference of the water and aliased lipid peak (in ppm), γ is 
the gyromagnetic ratio of hydrogen protons (42.58 MHz/T), and B0 is the static magnetic 
field strength (in Tesla). 
Simulations also demonstrated that the windowed Fourier spectral analysis using 
the Gaussian window would be able to suppress spectral sidelobes while maintaining 
water and lipid signal.  The lipid peak with a physiologically relevant magnitude (10% of 
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water) becomes more pronounced than the water sidelobes at a standard deviation of 0.73 
and the sidelobe to lipid ratio continues to decrease below this value.  The uncertainties in 
w lδ −  from 3.3-3.7 ppm decrease as σ approaches 0.4 then the uncertainties increase as σ 
increases.  Therefore, σ = 0.4 was used in the experiments involving the windowed 
Fourier method.   
Effects of the exponential window in simulation are shown in Table 4-1. The 
lowest relative lipid and water peak magnitudes are seen when the T2* of lipid is used for 
the window.  However, the uncertainty in w lδ −  was smallest (0.00144 ppm) when this 
value was used.  No matter which of the three T2* values were used, the exponential 
window decreased the uncertainty in w lδ − .  
Table 4-1  Effects of the exponential window on CSI spectra (53) 
Relative Lipid Magnitude Relative Water Magnitude Lipid/Water Magnitude Ratio Error in δW-L (ppm)
No Window 0.181 0.154 0.225 0.00554
Water T2* 0.404 0.373 0.207 0.00159
Lipid T2* 1.000 1.000 0.191 0.00144
Calculated T2* 0.248 0.218 0.217 0.00198
 
The effects of the exponential window at different T2* values at a frequency difference between lipid and 
water of 3.5 ppm.  If the lipid T2* can be determined, it introduces the largest signal as well as the lowest 
error in frequency estimation using a fast moment calculation. 
Table 4-2 shows the uncertainty of w lδ −  using a moment calculation with various 
values of spectral zero-filling, using the maximum value of each peak in a 1024-point 
spectrum, the SM algorithm’s calculation, and in the Gaussian fits.  The error shown is 
the root-mean-squared error over a simulated w lδ −   of 3.3-3.8 ppm.  The time to calculate 
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one spectrum was also recorded to reflect the relative speed of each technique, which is 
variable depending on the processing speed of the computer system being used.  The SM 
algorithm produced the lowest uncertainty of w lδ − , with only a small increase in 
processing time relative to Fourier-based processing.  This time also was less than the 
time required for fitting a Gaussian to each spectrum.  The moment calculation 
demonstrated the trade-off between accuracy and processing time.  In the experiments 
with short acquisition times, a moment calculation using 1024 points was used in the 
windowed Fourier calculations since only a small improvement in resolution (0.7 x 10-4 
ppm) was seen with a greater processing time (1.5 ms/spectrum) at 2048 points.  
Processing was on a 4Gflop CPU processor.   
Table 4-2  Processing computing performance in simulation (53) 
Processing Method Uncertainty in δW-L (10-4ppm) Processing Time (msec/voxel)
Moment
512 23.0 10.8
1024 20.1 11.1
2048 19.4 12.6
Peak Maximum 23.6 10.6
Steiglitz-McBride 0.02 16.6
Gaussian Fit 15.8 59.2
 
The uncertainty for various processing methods with processing times in msec/voxel in these calculations.  
The processing times are to demonstrate the relative speed of each method.  In this study, images were 
masked where only voxels with high signal relative to noise are processed.  
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Figure 4-1  The effects of the Lorentz-Gauss transform on MFGRE-CSI spectra 
(a) Unfiltered FFT in the phantom calibration ROI at 23.5 °C (dashed line) and 37.8 °C (solid line) with the 
presence of N/2 ghosts and sidelobes. (b) FFT spectrum with N/2 correction and Gaussian window (σ=0.4) 
applied resulting in minimization of sidelobes and N/2 ghosts with a mean reduction of peak magnitude of 
50.5%.  (c) FFT spectrum with the same N/2 correction and Gaussian window with an addition to the 
exponential window ( 30.9
TE
mse ) which increases both lipid and water peak magnitudes to 84.8% of the 
unfiltered peak magnitudes.  Reprinted with permission from the American Association of Physicists in 
Medicine, (53). 
4.3 Frequency, T2* and Amplitude Estimation with ARMA Modeling 
4.3.1 MATERIALS AND METHODS 
 The SM algorithm was tested, using Prony’s method as an initial estimate, on 
simulated signals for one- and two-peak systems.  In the one-peak system, acquisition 
parameters included spin lattice relaxation time (T1), which was set at 500 ms, and 
T2*=60 ms.  The TR was fixed at 70 ms to maintain consistent temporal resolution.  The 
minimum TE was set to 2 ms, with an echo-spacing of 3.3 ms.  The two-peak system 
added a lipid signal that had 25% of the amplitude of the water peak.  For the lipid peak, 
T1=300 ms and T2*=30 ms (74).  A flip angle of 37° (the Ernst angle for lipid signal (74) 
was used.  All other parameters were the same as those in the one-peak system.  To 
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simulate noise in both systems, Gaussian noise was added to real and imaginary channels 
of the complex time domain signal.  The SNR was defined as the amplitude of each 
spectral component divided by the standard deviation of the magnitude noise.  Using ten 
samples at SNR=2 and ETL=4, the standard deviation of the water PRF was 0.6174 ppm.  
If we want 95% confidence that the mean is off by at most 0.01 ppm, then the number of 
samples needed is  
2 2
9, / 2 2.262 0.6174 19504
0.01
t
n
e
α σ  ⋅ = = =  
  
   (4.3) 
Therefore, to obtain the measurement uncertainty, we performed 20,000 random trials at 
each SNR value (147).  Accuracies and uncertainties of the spectral parameters (chemical 
shift, T2* and complex amplitude) were calculated using the SM algorithm for an ETL of 
up to 16 echoes to determine, as a function of SNR, how the number of acquired echoes 
at a fixed ESP affected the accuracy and precision of the measured spectral parameters.    
 The Cramer-Rao lower bound (CRLB) was used to provide a comparative 
theoretical basis of the uncertainty independent of the spectral processing technique.  
This was used to test the performance of the algorithm in terms of precision.  The CRLB 
is defined as the minimum achievable variance for an estimator (148, 149).  The CRLB 
for this model (the sum of complex damped exponentials) has been analytically defined 
in a one peak system and can be numerically determined for a multi-peak system as 
described by Kumaresan and Tufts (54).  Detailed background and theory on the CRLB 
can be found in appendix A.   
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If an MR signal with only one peak is present, then the minimum uncertainty in 
the PRF, given by the CRLB, can be defined as   
0
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and SNRA is the SNR of the first echo (54).   
The uncertainties of the amplitudes, chemical shifts, and T2* values using the SM 
algorithm were compared to the CRLBs to ascertain the precision of the algorithm in the 
presence of noise.  Correlation coefficients between simulation values and the CRLBs 
were calculated for each parameter in both the one- and two-peak systems. 
The effects of ESP and T2* were simulated in the one-peak system with ETL=16.  
The uncertainty values for the chemical shift, T2*, and amplitude from 20,000 
measurements were determined as a function of ESP and T2* and represented on surface 
maps.   
 We also performed simulations to measure the sensitivity of detecting secondary 
peaks in noise.   In these simulations, the signal parameters were the same as those in a 
two peak system with an ETL=16, but the amplitude of water was changed to correspond 
to SNR for water of 10-50.  Measurements of sensitivity were made at different 
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secondary peak SNR levels to determine at which SNR the secondary signal could be 
detected.  This enabled the effects from water SNR, lipid SNR, and lipid/water ratios to 
be analyzed. 
4.3.2 RESULTS 
Precision of the SM algorithm on simulated data demonstrated a high correlation 
between the uncertainties in chemical shift and amplitude and the CRLB values for 
SNR>5 and ETL>4.  When uncertainties approached the CRLB, the algorithm performed 
near optimum at the theoretical lower bound of the uncertainty for the given model.  
Figure 4-2 displays the uncertainties in the signal-peak model using the SM algorithm for 
the chemical shift, T2*, and amplitude estimates as a function on of SNR for ETL of 4-16 
echoes.  Solid lines represent the CRLBs for each simulation.  As expected, he 
uncertainty of the estimates decreased as the SNR and number of echoes increased.  T2* 
measurements generally showed lower correlation (slightly higher uncertainty than the 
CRLBs), primarily at lower SNR values, than other spectral parameters.   This effect was 
expectedly exacerbated when using truncated ETLs (<8) which yield a reduced TEmax.  
For example, the uncertainty of measured T2* from simulations began to exceed the 
CRLBs at SNR<10 for ETL=8 and SNR<30 for ETL=4 (Figure 4-2).  Table 4-3 shows 
the correlation coefficients between the simulated data and the CRLBs.  In agreement 
with Figure 4-2, the chemical shift and amplitude showed very high correlation 
coefficients (Pearson’s R2>0.9990), with the correlation of the T2* measurements 
between simulation and the CRLBs decreasing as the number of echoes decreased. 
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Figure 4-2  Single-peak simulation and CRLB results  
Simulation and CRLB results for 4 (crosses), 8 (squares), 12 (triangles), and 16 (circles) echoes. This 
simulation used 20,000 trials. Estimates for chemical shift achieved an uncertainty at the CRLB for SNR≥5 
for each ETL (4–16 echoes) (a). The uncertainties in T2* for ETL=16 achieved the CRLB for all SNRs >5 
(b). As the ETL decreases, the uncertainty diverges from the CRLB. For instance, at ETL=8, the 
uncertainty is higher than the CRLB at SNR<10.Compared with the chemical shift (a) and T2* (b), the 
uncertainties of the amplitudes in the simulation and their CRLBs are less dependent on the number of 
echoes (c).  Reprinted with permission from the American Association of Physicists in Medicine, (150). 
 Table 4-3  Correlation coefficients between simulation and the CRLB in an one-peak signal  
Number of Echoes Chemical Shift T2* Amplitude
4 0.9997 0.7919 0.9996
8 0.9997 0.8886 0.9998
12 0.9996 0.9944 0.9999
16 0.9994 0.9996 0.9999
 
 
Correlation coefficients between simulation and the CRLB in a water-only signal over multiple echo-train 
lengths.   The uncertainties in chemical shift and amplitude have a very high correlation with the CRLB, as 
does the uncertainty in T2* at ETL=16. However, correlation between the uncertainties in T2* and the 
CRLB decreases as the number of echoes decreases.  Reprinted with permission from the American 
Association of Physicists in Medicine, (150). 
66 
 
The measured uncertainty of the chemical shift and T2* estimates demonstrated 
an inverse proportionality to the ETL, as expected from the derivation of the CRLBs (54).  
For SNR = 20, the dependence of the chemical shift and T2* on the number of echoes had 
a relationship of N-1.01 (Pearson’s R2 = 0.990) and N-1.02 (Pearson’s R2 = 0.980), 
respectfully, where N is the number of echoes.  The amplitude estimates exhibited less 
dependence on the number of echoes with a N-0.22  relationship (Pearson’s R2 = 0.982).  
Simulations also showed agreement between the spectral parameter uncertainties 
and the CRLBs in a two peak model representing water and lipid.  Figure 4-3 is a plot of 
the uncertainties and corresponding CRLBs for a simulated two-peak model of water and 
lipid for ETL=16.  Corresponding correlation coefficients are shown in Table 4-4.  
Uncertainties in the chemical shifts of both water and lipid signals approached the 
CRLBs and maintained high correlation coefficients.  As observed in the one-peak 
simulation of water, T2* values diverged more from the CRLBs than did other spectral 
parameters.  Uncertainties in the lipid chemical shift and T2* values were demonstrably 
higher, even for the same SNR.   Uncertainty in the amplitudes showed little difference 
between water and lipid.  This result was consistent in a range of water and lipid 
concentrations.  Further, as seen in the one-peak model, the uncertainty of each peak’s 
spectral parameters increased as the number of echoes decreased. 
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Figure 4-3  Simulation and CRLB results for a two-peak signal of water and lipid  
This simulation used 20,000 trials. Estimates for the chemical shift of both water and lipid achieved an 
uncertainty at the CRLB (a).  The uncertainties in T2* for both peaks reached their CRLBs. The T2* of lipid 
(30 ms) was set to half of that of water (60 ms) (b). The CRLB for the amplitudes of both water and lipid 
were similar when represented as relative uncertainties (c). The uncertainties provided by the algorithm had 
a similar result.  Reprinted with permission from the American Association of Physicists in Medicine, 
(150). 
 
Table 4-4  Correlation coefficients between simulation and the CRLB in a two-peak signal 
Water Fat
Number of Echoes PRF T2* Amplitude PRF T2* Amplitude
4 0.9753 0.5813 0.9997 0.9530 0.4811 0.9968
8 0.9758 0.6667 0.9999 0.9566 0.5495 0.9984
12 0.9810 0.7294 0.9999 0.9721 0.6811 0.9994
16 0.9886 0.9638 0.9999 0.9551 0.8435 0.9999
 
Correlation coefficients between simulation and the CRLB in a lipid-water signal over multiple echo-train 
lengths.   As with the one-peak (water only) signal, the uncertainties in chemical shift and amplitude have a 
high correlation with the CRLB for both water and lipid. The uncertainties in T2* correlate less with the 
CRLB as the number of echoes decreases.  Reprinted with permission from the American Association of 
Physicists in Medicine, (150). 
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Surface maps illustrated the impact of T2* and ESP on a one-peak model with 
ETL=16 (Figure 4-4).  Generally, the uncertainties were lower as T2* increased and the 
ESP decreased.  Areas below the black line in Figure 4-4 (a-c) indicate areas where the 
TE of the last echo (TEmax) was larger than the simulated T2*.  As expected, if collected 
echoes had TE values greater than the value of T2*, then the uncertainty of that estimate 
increased.     
 
Figure 4-4  ESP and T2* effects on the uncertainty 
Surface maps demonstrate the effects ESP and T2* (for a single-peak signal at SNR=20) have on the 
uncertainties for chemical shift (a), T2* (b), and amplitude (c). Areas below the black line represent where 
the ETL TEmax>T2*.  This causes an increase in uncertainty, which is more evident on (b) and (c). ESP>1.0 
ms can provide low uncertainties as long as the ESP is short enough not to sample above the T2* of the 
tissue.  Reprinted with permission from the American Association of Physicists in Medicine, (150). 
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In addition to precision, we also used simulations to test the accuracy of the SM 
algorithm.  Table 4-5 summarizes the measured accuracy of the estimates provided by the 
SM algorithm in a simulated water signal at SNR=20.  These estimates are presented as 
the root-mean squared error (RMSE).  The algorithm maintains high accuracy for the 
chemical shifts (<0.01 ppm) and amplitudes (<1.0%) for an ETL of 4-16.  This was 
consistent down to SNR=5.  T2* values also maintained high accuracy but increased to 
≥1% (0.6 ms) for ETL<5 at SNR=20.  For each parameter, the accuracy decreased with 
decreasing ETL and SNR, as expected.  Accuracies in the two-peak signals for the lipid-
water simulation are summarized in Table 4-6.  The RMSE values were higher for the 
water parameters in the lipid-water signal than those for the parameters of water in the 
water-only signal.  However, accuracy was high for both chemical shift and amplitude, 
<0.01 ppm and <1%, respectfully, for ETLs of 4-16.  At ETL≤6, the RMSE of T2* was ≥ 
6% for the longer T2* peak (water).  As expected, T2* measurements required a larger 
ETL to lower the bias when the ESP was fixed.   
The sensitivity of second peak detection in noise was also investigated using 
simulations.  Using lipid as a model for the second peak, it was observed that the 
sensitivity of locating the secondary peak depended on the relative SNR between the 
peaks as well as the individual SNR of each peak.   In a model with a simulated water 
signal and SNRs of 10-50, the simulated lipid peak was consistently detectable down to 
an SNR of 2.64 ± 0.48 for lipid/water amplitude ratios of  >0.05.   
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Table 4-5  Parameter accuracies in a water signal at a SNR of 20 
Number of Echoes Water PRF (ppm) Water T2*  (% Error) Water Amplitude (% Error)
4 0.000185 5.65 0.0402
5 0.000136 1.03 0.0402
6 0.000105 0.493 0.0382
7 0.0000844 0.246 0.0364
8 0.0000724 0.194 0.0347
12 0.0000429 0.107 0.0301
16 0.0000316 0.0760 0.0282
 
Accuracies (root-mean squared error) determined through simulation of 20,000 independent trials with a 
water signal at a SNR of 20.  High accuracy is achieved for the chemical shifts and amplitudes from four to 
sixteen echoes.  T2* values also has high accuracy but increases to > 1% (0.6 ms) at ≤5 echoes.  Reprinted 
with permission from the American Association of Physicists in Medicine, (150). 
 Table 4-6  Parameter accuracies in a water/lipid signal at a SNR of 20  
Number of Echoes Water PRF (ppm) Water T2* (% Error) Water Amplitude (% Error) Lipid PRF (ppm) Lipid T2* (% Error) Lipid Amplitude (% Error)
4 0.0083 42.1 0.425 0.0077 16.6 0.932
5 0.0067 38.4 0.322 0.0066 0.426 0.785
6 0.0047 6.52 0.227 0.0047 0.347 0.478
7 0.0027 0.474 0.136 0.0027 0.302 0.281
8 0.0021 0.225 0.106 0.0021 0.263 0.219
12 0.00047 0.113 0.0395 0.00048 0.166 0.0887
16 0.00018 0.0802 0.0293 0.00021 0.131 0.00715
 
Accuracies (root-mean squared error) determined through simulation of 20,000 independent trials with a 
water/lipid signal at a water SNR of 20.  The accuracy of chemical shift is within 0.01 ppm and that of 
amplitude is within 1% RMSE for ETLs of 4–16. At ETL≤6, the RMSE for both T2* values is high, 
especially for the longer T2* peak (water).  Reprinted with permission from the American Association of 
Physicists in Medicine, (150). 
4.4 Analysis of Acquisition Parameters 
4.4.1 FLIP ANGLE 
4.4.1.1 Materials and Methods 
It is expected that for a homogenous voxel, the lowest fσ ∆  should occur at the Ernst 
angle defined by 
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( )1 1cos TRTeθ −−=                                 (4.6) 
since SNRA is highest at this angle in a gradient echo acquisition.  To validate this, an 
agarose phantom (1.5 % w/v) was made with distilled, de-ionized water to minimize 
variation in the metal ion content of the water, which can lower relaxation times and 
affect SNR measurements.  Another phantom (agarose 1.5 % w/v) was made with 90% 
lemon juice and 10% mayonnaise to create homogenous lipid-water spectra throughout 
the phantom.  A plastic vial of vegetable oil was also scanned on the 1.5T clinical 
scanner.  The phantoms were stored in the MR scanner room overnight so their 
temperature would be equalized to that of the room.  The T1 and T2* values were 
estimated in a 3 x 3 voxel ROI in each phantom.  An MGE acquisition was performed 
(ETL=16 echoes; minimum TE (TE0)=2.0 ms; ESP=3.3 ms; TR=69 ms; rBW=244 
Hz/pixel; acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image; 
parallel imaging acceleration factor=2).  The flip angle was varied from 5° to 90° in 5° 
increments.  Assuming a one-peak model for the pure water and lipid phantoms, 
frequency maps were made and fσ ∆ as well as SNRA were measured in the same ROI 
where the T1 and T2* measurements were made.  The SNRA measures as a function of 
flip angle were compared to theory using the T1 and T2* measurements in both water and 
oil phantoms (SNR of a spoiled gradient echo acquisition, SNRA).  In addition, the 
uncertainty in ppm was plotted against 1/SNRA.  The slopes were compared where 
1/SNRA is the variable and the slope is the proportionality which is a product of all the 
constants in the equations 4.4 and 4.5.  In the SNRA and uncertainty plots, measurements 
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and theory were compared using a Student’s t-test assuming equal variances (F-test 
verified).  A two-peak model was used in the lipid-water phantom with separate field 
maps created for water and lipid and fσ ∆  of each field map was measured.  For each 
phantom, the uncertainty of the T2* and amplitude maps were measured as well.  
4.4.1.2 Results 
Figure 4-5 displays the uncertainties in the PRF (ppm), T2* (ms), and amplitude 
(CoV) as a function of flip angle in the pure water agarose phantom.  The Ernst angle was 
calculated to be 31.8 ± 0.3° (T1 = 409.5 ms) in the ROI where the uncertainty 
measurements were made.  Generally, as SNRA increased, the uncertainty of each 
spectral parameter decreases, as expected.  Figure 4-6 contains the measurements from 
the vegetable oil, which had a measured Ernst angle of 74.2 ± 0.4° (T1=52.2 ms). 
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Figure 4-5 Flip angle dependence on uncertainty and SNRA measurements in an agarose phantom 
Uncertainties in the PRF (ppm), T2* (ms), and amplitude (CoV) were measured as a function of the flip 
angle.  SNRA was also measured at flip angles between 5 - 90° at 5° increments.  Generally as SNRA 
increased, the uncertainty in each parameter decreased. The Ernst angle was measured as 31.8 ± 0.3°. 
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Figure 4-6 Flip angle dependence on uncertainty and SNRA measurements in a vegetable oil 
Uncertainties in the PRF (ppm), T2* (ms), and amplitude (CoV) were measured as a function of the flip 
angle.  SNRA was also measured at flip angles between 5 - 90° at 5° increments.  As with the agarose 
phantom, as SNRA increased, the uncertainty in each parameter decreased. The Ernst angle was measured 
as 74.2 ± 0.4°, which is expectedly higher than what was measured in the agarose phantom due to a shorter 
T1 (52.2 ms). 
Figure 4-7 displays the SNR of water and oil as a function of flip angle in addition 
to the SNR dependence in the uncertainty.  Using the calculated T1s and T2*s (409.5 ms 
and 63.4 ms for water, 52.2 ms and 25.4 ms for oil), the calculated SNR matched the 
measured values (p=0.14 and p=0.43 for water and oil, respectively).  The bottom plots 
measures the uncertainty in ppm as a function of 1/SNR which is shown in equation 4.23.  
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Using ESP=3.3 ms, ETL=16, and measured T2*, the constant from equation 4.4 was 
compared to the slope of the measured data.  Again, there were no statistical differences 
showing that the uncertainty follows what is predicted by CRLB analysis (p=0.24 and 
p=0.09 for water and oil, respectively).    
 
Figure 4-7 SNR and uncertainty measurements in phantom with comparison to CRLB theory 
Top:  Using the calculated T1 and T2* values, the calculated SNR matched the measured values (p=0.14 
and p=0.43 for water and oil, respectively).  Bottom:  The bottom plots measures the uncertainty in ppm as 
a function of 1/SNR which is shown in equation 4.4.  Using controlled acquisition parameters and T2* 
measurements, there were no differences between the measurements and CRLB analysis.    
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Figure 4-8 displays the parameter uncertainties in the lipid-water (mayonnaise-
lemon juice) phantom.  At flip angles of 30° and above, the uncertainties of each 
parameter stayed relatively constant. 
 
 
Figure 4-8 Flip angle dependence on uncertainty and SNRA measurements in a lipid-water phantom 
Uncertainties in the PRF (ppm), T2* (ms), and amplitude (CoV) were measured as a function of the flip 
angle.  Generally, uncertainties were lowest at higher flip angles.  This data suggests that higher flip angles 
are needed when lipid and water are both present in the voxel.   
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4.4.2 ECHO-SPACING 
4.4.2.1 Materials and Methods 
In the Fourier approach, large spectral leakage, manifested as sidelobes, made the 
echo spacing become confined to a small range so peaks do not overlap.  The ARMA 
modeling approach may allow more flexibility in the echo spacing allowing even lower 
bandwidths and, therefore, higher SNR.  Experiments were performed to determine the ESP 
that reduces the uncertainty without peak overlapping.  To test this, the lipid-water phantom 
(1.5% w/v) was scanned on a 1.5T clinical scanner with the echo-spacing varying from 
3.3 to 4.3 ms (ETL=16 echoes; minimum TE (TE0)=2.0 ms; TR=69 ms; FA=30°; 
rBW=244 Hz/pixel; acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 
sec/image; parallel imaging acceleration factor=2) at room temperature. fσ ∆ values of 
water and lipid were recorded as a function of ESP in a 3x3 ROI.  Data analysis 
determined the low values of fσ ∆  in both water and lipid while discerning ESP values to 
avoid due to peak overlapping. 
Simulations were also performed to ascertain the effects of SNR on the precision 
when the peaks are close together due to increasing ESP.  Using the same simulation 
protocol as in the SM algorithm simulation study, the ESP was varied from 3.4 to 4.2 ms 
as a function of SNR.  The uncertainties in the water and lipid PRF were determined.   
4.4.2.2 Results 
The uncertainties in temperature (using -0.0097 ppm/°C for water and -0.0088 
ppm/°C for the difference PRF) are shown at various ESP values (Figure 4-9).  The 
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uncertainties remain under 1.0 °C for water and 2.0 °C for when lipid is used as a 
reference at ESP of 3.3 to 3.8 ms.  At 3.9 ms and above, uncertainties increase largely 
due to the inability to precisely ascertain the lipid peak.  Note that the uncertainty in the 
water peak does not go above 1.0 °C except at 4.0 ms where the value is 2.1 °C.  At 4.1 
ms, the uncertainty in the water peak PRF goes to 0.9 °C although the lipid PRF 
uncertainty is relatively high at 7.5 °C.    
Figure 4-10 shows the uncertainties in the T2* and amplitude for each peak.  As 
with the PRF, the peak overlaps affect the secondary peak (in this case lipid) more 
compared to the dominant peak (in this case water). 
 
Figure 4-9 Influence of ESP on the precision of temperature estimates 
Uncertainties in temperature are shown as a function of ESP.  The water PRF relatively maintains precision 
indicating that the dominant peak can still be detected precisely even when peaks overlap.  The precision of 
the secondary peak, which is lipid in this case, loses precision.  From this plot, the uncertainty of the lipid 
PRF becomes quite high when the ESP is 3.9 to 4.3 ms.  Error bars represent the standard deviation of the 
measurements. 
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Figure 4-10  Influence of ESP on the precision of T2* and amplitude estimates 
Uncertainties in T2* (left) and amplitude (right) are shown as a function of ESP.  As with temperature, the 
water relatively maintains precision.  The precision of the secondary peak, lipid, loses precision.  From 
these plots, the uncertainty of the lipid parameters becomes high when the ESP is 3.9 to 4.3 ms and, thus, 
should be avoided if precise lipid estimation is needed in areas where water is dominant (such as the liver).  
Error bars represent the standard deviation of the measurements. 
 
 Figure 4-11 shows the influence of the ESP and SNR on the PRF uncertainty.  As 
SNR increases, the ability to ascertain the water and lipid PRF increases even if the peaks 
are close together.  Therefore, if two peaks are close together due to the actual physical 
properties of the signal or an ESP where lipid aliases over water, higher SNR can 
distinguish the two peaks.   
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Figure 4-11  PRF precision as a function of SNR over variable ESP 
As SNR increases, the precision of the PRF estimates increases.  Even at an ESP where the lipid aliases 
into the lipid peak (4.2 ms), the water PRF can be measured with high precision.  Therefore, if ESP values 
are chosen that may cause the lipid to alias to the water, higher SNR is needed to precisely measure the 
primary peak PRF.    
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4.4.3 ECHO TRAIN LENGTH 
4.4.3.1 Materials and Methods 
When SNR is high, then the ability to reduce the ETL is possible to either 
increase spatiotemporal resolution or increase the number of imaging planes.  To test this, 
the agar water and lipid-water phantoms were scanned on a 1.5T clinical scanner 
(minimum TE (TE0)=2.0 ms; ESP=3.3 ms; TR=69 ms; FA=30°; rBW=244 Hz/pixel, 
acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image; parallel 
imaging acceleration factor=2) with ETL values of 4, 8, 12, and 16.   
In addition, a second series of scans were obtained with the agar phantom using 
similar acquisition parameters except that the TR was adjusted where it would be the 
minimally allowed TR for a given ESP and ETL.  The TR values chosen for ETL values 
of 4, 8, 12, and 16 were 14.1, 28.0, 41.0, and 54.0 ms, respectively.  These resulted in 
acquisition times of 0.9, 1.8, 2.6, and 3.5 seconds, respectively.   The uncertainties of the 
PRF, T2* and amplitude were measured as a function of ETL. 
4.4.3.2 Results 
At a constant TR, the uncertainty in the measurement of each spectral parameter 
was found to be inversely proportional to the ETL (Figure 4-12).  This is expected since 
the more samples obtained, the more likely the ARMA model can approximate the signal.  
Interestingly, even at an ETL of 4, the uncertainty was less than 0.01 ppm which is 
consistent what was seen in simulation (see Table 4-5).  As long as the T2* extends the 
longest TE (see Figure 4-4), the precision of the T2* measurements increases with ETL 
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much as what is expected with exponential fitting of magnitude data.  Also note that the 
dependence in the amplitudes is comparably less dependent on ETL in regards to PRF 
and T2*.  This is also consistent to what was seen in simulation (see section 4.3.2).   
 
Figure 4-12  Influence of ETL on the precision of spectral estimates in a water phantom 
Uncertainties in PRF (top left), T2* (top right) and amplitude (bottom) are shown as a function of ETL.   At 
a constant TR, the uncertainty in the measurement of each spectral parameter was found to be inversely 
proportional to the ETL.  This is consistent with the simulations (150).    
 
 In the presence of lipid, the precision of each parameter stayed relatively constant 
at ETL values of 8, 12, and 16.  When 4 echoes were used, the uncertainty of each 
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parameter increased.  For temperature imaging, it appears that 8 echoes or more could 
possibly be used in planes where lipid and water are present in the same voxels.   
 
 
Figure 4-13  Influence of ETL on the precision of spectral estimates in a lipid-water phantom 
Uncertainties in PRF (top left), T2* (top right) and amplitude (bottom) are shown as a function of ETL in a 
lipid-water phantom.   The uncertainty in the PRF is relatively constant from 8-16 echoes which suggest 
that 8 echoes could possibly be used in voxels with lipid and water for temperature imaging.  There is 
higher uncertainty, however, in the amplitude estimates at 8 echoes.      
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Figure 4-14 shows the uncertainty in the spectral parameters when a shortened TR 
is used to increase the temporal resolution and maintain spatial resolution.  Compared to 
the constant TR, the uncertainties were higher due to lower SNR.  The uncertainties in 
the PRF at ETLs of 4 and 8 were statistically different (p<0.01 ppm and p=0.02, 
respectfully).   When compared to the same ETL, all the T2* and amplitude uncertainties 
where statistically different (p<0.01).  As an illustrative example of how SNR plays a 
factor in the uncertainty, Figure 4-15 shows the constant TR case compared to the shorter 
TR acquisition where SNR losses due to the change the TR are accounted for.   
 
Figure 4-14  Influence of ETL on the precision of PRF, T2*, and amplitude estimates 
Uncertainties in PRF (top left), T2* (top right) and amplitude (bottom) are shown as a function of ETL.   At 
the shortest TR for the given ETL, the uncertainty in the measurement of each spectral parameter was 
found to be inversely proportional to the ETL.  This dependence is higher than when a constant TR was 
used.  The T2* of the phantom was 63.4 ms.     
85 
 
 
Figure 4-15  Uncertainties in the amplitudes with SNR compensation 
At a shorter TR, the SNR of the acquisition will be lower.  If the SNR of the constant TR acquisitions are 
decreased by compensating for the difference in TR, then it matches what was measured in the lower TR 
acquisitions.  In other words, the lower TR acquisition suffers an SNR loss and this directly increases the 
uncertainty, as expected.  In the amplitude estimate, the uncertainty in the lower TR scans are due purely 
from a difference in SNR. 
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4.4.4 PERFORMANCE OVER VARIABLE T2*  
4.4.4.1 Materials and Methods 
To test the precision of the temperature estimates over a range of T2* values, seven 
agar phantoms were created with varying concentrations of superparamagnetic iron oxides 
(SPIOs) which effectively changes the T2* of phantom (151).  The T2* of each phantom was 
determined via exponential fitting using a standard SPGR sequence with varying TE.  Using 
the determined acquisition parameters and spectral processing algorithms, field maps were 
made from all seven phantoms scanned (ETL:4-16; minimum TE (TE0)=2.1 ms; ESP=3.3 
ms; TR=69 ms; FA=30°; rBW=244 Hz/pixel, acquisition matrix=128x128; voxel 
volume=1.6x1.6x4.0 mm3; 5 sec/image; parallel imaging acceleration factor=2).  fσ ∆  
SNRA was measured in a 3 x 3 voxel ROI in each phantom.  φσ ∆  was be measured in each 
ROI as well at each echo.  Both fσ ∆ and φσ ∆  will be divided by the TSC to represent the 
uncertainty in temperature.  A Student’s t-test with equal variances (F-test tested) was 
employed to test for differences in the two precision values.  If fσ ∆ < φσ ∆  for each ROI , then 
the proposed technique will show increased sensitivity at that T2* value.  Using the SNR of 
the first echo and the measured T2*, the CRLB was also calculated. 
 
4.4.4.2 Results 
Table 4-7 displays the uncertainty in the CSI and CPD measurements (the lowest 
over all the echoes) in each phantom.  The CSI technique at least matched the CPD 
technique in terms of uncertainty and actually performed better at 6.4 and 21.2 ms 
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(p<0.05).  In every case, the CSI measurements matched the CRLB at the 95% 
confidence interval.  Note that the CPD measurement was at the echo of least uncertainty.  
As will be discussed in the next chapter, the T2* changes with temperature so the TE 
chosen for CPD methods may not be optimal over the entire course of treatment.  In the 
CSI method, we measured high precision without constraining to specific TE values (see 
equations 2-13 and 3-6).0  This data also supports published data obtained in ex vivo 
kidney tissue (53), which investigated the noise characteristics between CPD and this CSI 
technique.   
Table 4-7  Noise characteristics of CSI and CPD over a range of T2* values 
T2* CRLB (°C) 
Unc. CSI 
(°C) 
Unc. CPD 
(°C) p-value  
6.4 1.52 1.21 ± 0.39 2.13 ± 0.74 0.03 
12.9 0.21 0.20 ± .02 0.24 ± 0.07 0.24 
14.6 0.17 0.18 ± .02 0.23 ± 0.09 0.21 
21.2 0.11 0.11 ± 0.02 0.20 ± 0.06 0.02 
47.1 0.07 0.07 ± 0.01 0.10 ± 0.05 0.18 
51.6 0.07 0.06 ± 0.02 0.09 ± 0.04 0.25 
63.4 0.07 0.07 ± 0.01 0.09 ± 0.03 0.38 
 
The CSI technique at least matched the CPD technique in terms of uncertainty.  At 6.4 and 21.2 ms, the 
uncertainty with the CSI technique was lower when compared to CPD.  Each CSI noise measurement 
encompassed the CRLB at the 95% confidence interval while this was not always the case with CPD.   
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4.5 Discussion    
What makes this work different from previously published work (37, 45-48, 152) is 
not the sequence itself, but rather the approach taken in setting acquisition parameters, 
the efficient use of the imaging time and data generated, and the approach to post-
processing of the low resolution, aliased spectral data.   
 Our simulations and results from phantom studies demonstrate that processing 
algorithms discussed in this study can measure these frequency shifts with a high degree 
of accuracy even when the lipid peak is aliased, and that the SM algorithm is useful in 
overcoming the limitations of conventional windowed Fourier-based methods.  The 
relaxation of the ESP constraint gave us the ability to use lower receiver bandwidths 
allowing higher SNR.  Also, while only a few echoes were used, the relaxed ESP helped 
maintain reasonable spectral resolution.   Additionally, the frequency difference between 
water and lipid is well known in the range of temperatures used for thermal therapy, so 
the ESP can be determined and ued to avoid problems with N/2 ghosts associated with 
bipolar readout gradients and aliasing the lipid peak too close to the water peak.   
  Another assumption we made was that we could accurately monitor peak shifts 
using only 16 echoes.  While this could be accomplished using windowed Fourier 
techniques and peak finding routines, we applied a non-Fourier technique based on 
ARMA analysis of the data in order to provide a more robust method for finding peaks, 
as well as estimating the T2* and amplitude for each peak.  This is in contrast to well-
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known lipid-water separation techniques where peak amplitude quantification is of 
primary concern (128, 135, 137).  
We observed robust performance of the SM algorithm in accuracy, uncertainty, 
and secondary peak detection across a range of SNR values for a very low number of 
echoes.  The use of minimal samples represented as a rational polynomial in the z-
domain, which has been shown to converge exponentially as the number of echoes 
increases (118), is important because this allows the acquisition either to run faster with 
less computational overhead or to facilitate the acquisition of multiple slices within the 
same TR period.  For example, using the minimum TR possible with an ETL=8 and 
ESP=3.3 at 1.5T, acquisitions could be performed in less than two seconds.  Three slices 
could be encoded in less than six seconds. 
In addition to choosing a low number of echoes, the choice of other acquisition 
parameters, such as the ESP, can affect the accuracy and precision of the measurements. 
We have shown that choosing ESPs that extend TEmax past the T2* of the tissue increases 
the uncertainty in the measurements (Figure 4-4).  In low T2* tissues or where there is 
low SNR in the later echoes, those echoes should be dropped since an increase in 
uncertainty has been observed.  For instance, in a signal with a T2*=10 ms, TEmax=51.2 
ms and SNR=20, sampling 16 echoes gave an uncertainty of 0.0154 ppm whereas 
sampling 8 echoes reduces the uncertainty to 0.0044 ppm.  Therefore, for signals with 
low SNR (<5) at the later echoes, it is better to exclude those echoes and proceed with a 
lower ETL than to include them.   
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Theoretical calculation of the CRLB demonstrates that the uncertainty is inversely 
proportional to the SNR, a relationship corroborated by simulation and phantom 
measurements.  Therefore, MR acquisition parameters, such as the flip angle, should be 
chosen to increase the SNR of the peak of interest.  For instance, in a one-peak system, 
the flip angle that provides maximum SNR is the Ernst angle.  For two-peak systems in 
which information from both peaks is desired, acquisition parameters should be tailored 
to help increase the SNR of the secondary peak, which was assumed here to be the 
smaller of the two.  If TR is fixed for optimal timing, the flip angle could be used to 
provide optimal modulation of the secondary peak signal.   
Given adequate SNR, the acquisition used in this work could provide T2* maps of 
8-10 slices in a single breathhold (<20 s) using ETL=8, while also providing inherent 
lipid suppression.  A recent study in liver constrained the solution of the estimated tissue-
based T2* for water by assuming equivalent T2* values for water and lipid, owing to a 
heavy iron overload (138).  The authors concluded that this assumption may not be 
reasonable.  The technique investigated here could potentially be used to separate these 
T2* values directly, without any assumptions on the chemical shift or T2* equivalency, 
thereby allowing identification of separate T2* values for water and lipid.  Another 
potential application is quantitating the distribution of superparamagnetic iron oxides 
(SPIOs) (153).  These particles have been suggested for use in thermal therapy, and such 
therapies could potentially benefit from the temperature imaging capabilities of our 
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technique as well (154).   Our data shows that precision can be maintained through a 
wide range of SPIO concentrations.  
Our simulations and phantom experiments also show that for the same imaging 
time and parameters, this technique is more precise than current CPD techniques over a 
wide range of SNR  values because it maintains better accuracy and precision across a 
variety of T2* values and thus improves sensitivity of temperature imaging (Fig. 4-16).  
Therefore, our data supports the hypothesis for increased accuracy and precision 
compared to CPD.   
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Figure 4-16 The uncertainty in temperature versus imaging SNR for a signal containing 25% lipid  
The simulation (n = 20,000 samples) for evaluating the uncertainty in the signal for water using the SM 
algorithm (circles) is compared with CRLB results (solid line). Note that our algorithm stays close to the 
CRLB over a wide range of SNRs. For reference, the CPD results are shown for an optimal TE (TE=T2*) at 
the same bandwidth as the 16-echo sequence (black diamonds) and at one half this bandwidth (white 
diamonds) as would more likely be used. This case also assumes that the CPD can perfectly remove the 
influence of the lipid signal, which is unlikely; thus, it stands as a "best case" scenario for CPD against our 
technique. As can be seen, in addition to providing lipid-water separation, the fast CSI approach easily 
outperforms the CPD approach across a large range of imaging SNR values for the same imaging time.  
Reprinted with permission from the American Association of Physicists in Medicine, (150). 
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Chapter 5: Fast CSI Temperature Measurements in 
Phantom and Ex Vivo Tissues  
5.1 Introduction 
The MR acquisition strategies and spectral processing algorithms discussed in 
chapter 4 were applied to thermal therapies in phantom and ex vivo tissues.  The overall 
goal in this chapter is to show the increased accuracy and precision compared to 
calculating the complex phase difference (CPD) as well as to show the advantages of this 
technique for multi-parametric monitoring.  First, calibrations of the PRF shift with 
temperature change in a lipid-water phantom as well as ex vivo canine bone marrow, 
brain, prostate, kidney and liver tissues were performed.  These calibrations will be 
reported and discussed with emphasis on how the presence of lipid can affect the water 
PRF shift.  Next, the temperature responses of R2* and signal amplitude are measured in 
these tissues.  These parameters, which are simultaneously measured with temperature, 
are investigated for their usefulness in thermal therapy monitoring.     
5.2 PRF Calibration in Phantom 
5.2.1 MATERIALS AND METHODS 
A phantom containing 50% lemon juice and 50% mayonnaise (by volume) (45) 
was used in order to test the temperature monitoring capabilities of the MGE acquisition 
and SM algorithm in voxels containing homogenous lipid and water signals.  The mixture 
was contained in a 50 ml plastic vial and placed in a calorimeter consisting of two 
insulated cups.   A fluoroptic temperature monitoring fiber (M3300, Luxtron, Santa 
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Clara, CA) was placed in the phantom and the entire apparatus was placed in an 8-
channel high resolution brain array (MRI Devices, Waukesha, WI) for imaging on a 1.5T 
clinical MR scanner (Excite HD, GE Healthcare, Waukesha, WI).  The fluoroptic fiber 
was localized using T1-W images.  For this calibration experiment, the acquisition time 
was slowed to 10 seconds per acquisition to reduce the number of images acquired during 
the entire 15 minutes of continuous scanning.  The MGE acquisition used a parallel 
imaging acquisition (SENSE) with an acceleration factor of 2.  The minimum TE was set 
to 2.6 ms with an ESP of 3.3 ms (303 Hz spectral bandwidth) for the 16 acquired echoes.  
The TR was 140 ms and the acquired voxel volume was 0.78 x 1.6 x 3.0 mm.  The flip 
angle was set to 60° to increase the lipid signal.  The receiver bandwidth to achieve the 
desired ESP was ±41.7 kHz (325 Hz/pixel) with a matrix size of 128 (phase encodes) x 
256 (frequency encodes).  After acquisition of 3 baseline scans, 300 ml of 90°C water 
was poured through a tube into the calorimeter.  The imaging plane was chosen so that 
the flowing water in the image was in the frequency encode direction to avoid artifacts in 
the phase-encode direction associated with the aliasing from the SENSE-parallel imaging 
acquisition. In addition, the volume of water used was limited to keep the water signal 
from appearing in the coronal slice we were monitoring. 
 A 2x2-voxel region of interest (ROI) was selected at the point in the image at the 
end of the fluoroptic probe.  The SM algorithm was also employed to estimate the water 
and bulk methylene PRF shifts.  Peak shifts estimated by the technique were plotted 
against the temperature measured by the fluoroptic probe in order to calculate the 
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temperature sensitivity coefficient in ppm/°C.  Linear fits were calculated for the plot 
using least-squares regression.     
Maps were created using the CPD method at the echo time close to the lipid T2* 
(TE = 32.6 ms).  A Student’s t-test was used to find statistical significance between the 
temperature readings from these three methods and the fluoroptic fiber’s measurements.   
5.2.2 RESULTS 
Temperature calibration curves for the lipid-water phantom experiment using the 
SM algorithm are shown in Figure 5-1.  The temperature sensitivity coefficients 
calculated for each curve were -0.0096 ± 0.0003 ppm/°C (Pearson’s R2 = 0.995) and -
0.0007 ± 0.0005 ppm/°C (Pearson’s R2 = 0.436) for water and lipid, respectively.  The 
temperature sensitivity coefficient based on the difference between the lipid and water 
peaks was  -0.0088 ± 0.0005 ppm/°C (Pearson’s R2 = 0.994) and this value is similar to 
published data when the water PRF accounted or corrected for susceptibility (37, 43, 45).   
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Figure 5-1 The temperature calibration curves of the lipid-water phantom  
The lipid and water curves are shown in (a) and the difference between the two peaks, 
w lδ − , in (b).  A 
strong linear dependence can be seen in the water peak and the difference between the peaks.”  The 
temperature sensitivity coefficients calculated for each curve were -0.0096 ± 0.0003 ppm/°C (Pearson’s R2 
= 0.995), -0.0007 ± 0.0005 ppm/°C (Pearson’s R2 = 0.436) and -0.0088 ± 0.0005 ppm/°C (Pearson’s R2 = 
0.994) for water, lipid and the difference in the PRF values, respectively.  Reprinted with permission from 
the American Association of Physicists in Medicine, (53). 
 
 
97 
 
 
Temperature measurements with and without using a lipid reference as well as the 
CPD measurements were obtained (Fig. 5-2).  The calculations were performed using the 
same ROI where the calibration data was measured.  During the calibration, the hot water 
poured into the calorimeter caused a large shift in the mixture’s water and lipid resonance 
frequencies.  This caused the RMSE for the CPD and water CSI temperature readings to 
be 21.3 °C and 20.3 °C, respectfully.  These two measurements were significantly 
different when compared to the fluoroptic fiber measurements (p<0.0001).   However, 
when lipid was used as an internal reference the temperature remained accurate when 
compared to the fluoroptic fiber measurements.  The RMSE between the lipid-referenced 
CSI and the fluoroptic fiber was 0.44 ± 0.34 °C.  There was no statistically significant 
difference between the CSI using lipid as a reference and the fluoroptic fiber 
measurements over all the time points. 
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Figure 5-2 The measured change in temperature in the lipid-water phantom over time  
Field shifts from the pouring water causes the CPD (∆T(∆φ)) and CSI (water frequency only, ∆T(δW)) to be 
21.3 °C and 20.3 °C, respectfully.  The CSI using lipid (∆T(δW-L)) as a reference corrects this error.  
Reprinted with permission from the American Association of Physicists in Medicine, (53). 
 
5.3 PRF Calibration in Ex Vivo Tissue 
5.3.1 MATERIALS AND METHODS 
Canine bone marrow, brain, kidney, liver and prostate tissue were treated with a 
water-cooled applicator housing a 980-nm laser fiber with a 1-cm diffusing tip powered 
by a 15 W diode laser source (BioTex Inc., Houston, TX) on a clinical MR scanners at 
1.5T (Excite HD, GE Healthcare, Waukesha, WI) and 3T (TwinSpeed Excite HD, GE 
Healthcare, Waukesha, WI).  A fluoroptic temperature probe (M3300, Luxtron, Santa 
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Clara, CA) was inserted in order to provide an absolute measurement of temperature.  In 
each ablation, the multi-gradient echo (MGE) acquisition was used (1.5T: ETL=16 
echoes; minimum TE (TE0)=2.0 ms; ESP=3.2 ms; TR=69 ms; FA=30-40°; rBW=244 
Hz/pixel, acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image; 
parallel imaging acceleration factor=2. 3T: TE0=2.1 ms; ESP=1.8 ms; rBW=325 
Hz/pixel). Echoes were acquired with identical polarity gradients separated by flyback 
rewinder gradients.   
A 2 x 2-voxel ROI adjacent to the sensitive region of the fluoroptic probe was 
chosen and the PRFs were measured as a function of temperature to calculate the 
temperature sensitivity coefficient (TSC).  The water PRF was measured for all tissues.  
For bone marrow, water and bulk methylene proton resonances were measured at 1.5T 
while terminal methylene and methyl peaks were included in studies at 3.0T.  Slope, 
intercept, and correlation coefficient measurements were calculated for each temperature 
sensitivity calibration using linear least-squares regression analysis.  The temperature 
estimates using the calculated TSC were correlated to the fluoroptic probe measurements.  
Estimates were also compared to CPD-measured water PRF calibration using a paired 
two-tailed Student’s t-test.   Estimated uncertainties (noise) from each calculated 
parameter in bone marrow were measured as the standard deviation and compared with 
the calculated CRLB for the acquisition, which represents the theoretical lower bound of 
the uncertainty (54, 150).  Temperature uncertainties calculated from the measured TSC 
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and PRF uncertainties were compared to temperature uncertainties from the complex-
phase difference using the echo from the MGE acquisition with the least uncertainty.    
5.3.2 RESULTS 
In bone marrow, water, bulk methylene, terminal methylene and methyl peaks 
were resolvable at 1.5T and 3.0T. Figure 5-3 demonstrates representative modeled 
spectra from ex vivo bone marrow observed using the spectral parameters derived from 
the SM algorithm at 1.5T (a) versus the unfiltered FFT spectrum (with 1024 zero padded 
interpolation) and the modeled spectra at 3.0T (b).  The SM algorithm rapidly and 
accurately located water and lipid chemical shifts despite the low spectral resolution of 
the acquisition, which caused large sidelobe contamination in the Fourier analysis.  
Although spectral apodization techniques could be employed with the FFT technique, the 
tradeoff is one of spectral resolution versus sidelobe interference.  In (b), as temperature 
rises, the water peak shows a notable shift in the PRF compared to the three lipid peaks.  
Spectra obtained from a point resolved spectroscopy (PRESS) (TE/TR: 144/2000) 
acquisition show the unaliased lipid peaks and the water peak (c). 
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Figure 5-3 Representative measured bone marrow spectra from 16-echo MGE and PRESS  
At 1.5T (a) a 4-peak ARMA modeling (solid) versus unfiltered FFT (1024 point interpolation) (dashed).  
As previously confirmed (17), ARMA peak locations do not suffer from truncation artifacts.  At 3.0T (b) 
four-peak model at 17.0°C (solid) and 42.5°C (dashed) demonstrates temperature dependent water PRF and 
temperature independence of lipid peak PRFs.  For comparison, a spectrum from a PRESS acquisition is 
shown in (c).    
As expected, excellent correlation with fluoroptic temperature measurements 
were observed in the water PRF but not in the lipid PRF.  The data in Table 5-1 
quantifies temperature relationships observed during calibrations at 1.5T over the 
temperature range of 17.2 to 57.0 °C.  Figure 5-4 demonstrates the change in the water 
(squares) and bulk methylene (diamonds) PRF as a function of fluoroptic temperature 
measurement at 1.5T.  The TSC of the difference between the water and lipid PRF values 
in both calibrations were found to be statistically equivalent (-0.87x10-2 ± 2.7x10-6 
ppm/°C (R2=0.942), -0.87x10-2 ± 4.6x10-4 ppm/°C (R2=0.961) and -0.85x10-2 ± 3.2x10-4 
(R2=0.920), 0.17 < p < 0.99).  Using these TSC values, the RMSE between the 
temperature estimates and the fluoroptic probe was 0.39 ±0.21°C (Range: -0.29 – 0.90 
°C) for calibration 1, 0.96 ± 0.25°C (Range: -0.54 – 1.13 °C) for calibration 2 and 0.54 ± 
0.13 °C (Range: -0.84 – 0.93 °C) for calibration 3.  If the temperature measurements were 
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made using water PRF without lipid correction along with the TSC of the water PRF 
only, the RMSE values were 1.03 ±0.12 °C (Range: -1.36 – 1.69 °C), 2.11 ± 0.24 °C 
(Range: -1.41 – 2.69 °C) and 1.31 ± 0.31°C (Range: -1.22 – 2.91 °C) for calibrations 1, 2 
and 3, respectively.  The CPD RMSE was 2.34 ± 0.25 °C, which was statistically 
different from the CSI measurements (p<0.001). 
Table 5-1  Measured PRF temperature sensitivity coefficients from three bone marrow calibrations 
at 1.5T 
 
Chemical Shift  
Temperature 
Sensitivity Coefficient  
[ppm/°C] (R
2
)  
Water 
-1.07x10
-2
 ± 1.0x10
-4
 
(0.981) 
-1.11x10
-2
 ± 2.4x10
-4
 
(0.974) 
-0.98x10
-2
 ± 1.3x10
-4
 
(0.969) 
Bulk Methylene 
-0.20x10
-2
 ± 1.0x10
-4
 
(0.438) 
-0.24x10
-2
 ± 1.5x10
-4
 
(0.738) 
-0.12x10
-2
 ± 1.1x10
-4
 
(0.440) 
Difference 
-0.87x10
-2
 ± 2.7x10
-4
 
(0.942) 
-0.87x10
-2
 ± 4.0x10
-4
 
(0.961) 
-0.85x10
-2
 ± 3.2x10
-4
 
(0.920) 
 
 
  
  
The difference is between the water and bulk methylene PRFs which is consistent between calibrations and 
agrees with lipid-water phantom data (45, 53). 
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Figure 5-4 Temperature calibration curves for one bone marrow calibration at 1.5T   
The temperature sensitivity coefficients (TSCs) of the water (squares) and lipid (diamonds) PRFs were -
0.98x10-2 ± 1.3x10-4 (R2=0.969) and -0.12x10-2 ± 1.1x10-4 (R2=0.440), respectfully.  By taking the 
difference of the two PRFs as a function of temperature, the TSC was -0.85x10-2 ± 3.2x10-4 (R2=0.920).   
 
The temperature measurements from the CSI technique compared to the true 
temperature calculated by the fluoroptic probe in calibration 1 are shown in Figure 5-5.  
The slopes of the regression lines for the water-bulk methylene temperature readings and 
the water PRF were 0.999 ± 0.021 ppm/°C (R2=0.987) and 0.988 ± 0.072 ppm/°C 
(R2=0.942) with intercepts at 0.03°C and 1.01°C, respectfully.  For comparison, the solid 
line shown has a slope of unity.  If the difference in the water PRF alone was used for 
temperature monitoring, it would tend to overestimate the temperature (p<0.001). 
104 
 
 
Figure 5-5 Temperature measurements from the CSI technique compared to the true temperature 
calculated by the fluoroptic probe.   
The RMSE for the susceptibility-corrected temperature readings and the water PRF readings were 0.393 °C 
and 1.031 °C.  The slopes of the regression lines for the water-lipid temperature readings and the water 
PRF were 0.999 (R2=0.987) and 0.988 (R2=0.942) with intercepts at 0.030°C and 1.014°C, respectfully.   
For comparison, the line shown in the figure has a slope of unity. 
 
The measured uncertainties in the spectral parameter estimations made using the 
2-peak model at 1.5T are summarized in Table 5-2.  Values in parentheses are the 
calculated theoretical uncertainty for the acquisition provided by the CRLB.  The 
measured uncertainties agree with the CRLB at the 95% confidence interval.    Using the 
calculated TSC values, the temperature uncertainty was calculated as 0.58 ± 0.09 °C 
when the difference of the water and lipid PRF values was used for temperature 
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measurements.   Comparably, the uncertainty in the CPD was measured as 1.46 ± 0.19°C 
using the echo from the acquisition with the least uncertainty (TE=14.8 ms) (p<0.01).   
Table 5-2   Measured uncertainties in the estimated spectral parameters in bone marrow at 1.5T   
Parameter Water (CRLB) Bulk Methylene (CRLB)
PRF (ppm) 0.00355 ± 0.00054 (0.004) 0.00191 ± 0.00035 (0.002)
T2* (ms) 2.27 ± 0.51 (2.22) 0.48 ± 0.14 (0.57)
Amplitude (CoV) 0.023 ± 0.009 (0.018) 0.017 ± 0.004 (0.015)
 
The CRLB is within the 95% confidence interval in each of the parameters.   
 
The mean spectral parameter estimations measured at 3.0T resulting from 
application of a 4-peak model in bone marrow are also summarized in Table 5-3.  The 
TSCs of these peaks over a temperature range of 18.4 to 57.2 °C are shown in Table 5-4.  
As with the 1.5T calibrations, the water-bulk methylene TSC was statistically equivalent 
(p=0.11).  Using the temperature sensitivity of the difference in the water and bulk 
methylene PRF, the RMSE values compared to the fluoroptic probe were 0.19 ±0.06°C 
and 0.59 ± 0.24°C for the two calibrations.  Using CPD with a TE of 9.1 ms, the RMSE 
was 1.89 ± 0.15°C.  This was statistically different from the CSI RMSE (p<0.001).  The 
noise in the temperature estimates using bulk methylene as an internal reference was 
measured at 0.78 ± 0.08 °C.  The noise in the temperature estimates were higher, 2.87 ± 
0.05 °C and 3.21 ± 1.12 °C, when using the lower SNR terminal methylene and methyl 
protons, respectively, as internal references.  Using the mean of all three lipid peaks as a 
reference, the uncertainty was lower at 1.00 ± 0.02 °C. Using the water peak only with its 
measured TSC, uncertainty was 0.91 ± 0.38 °C.  Uncertainty in the CPD was measured as 
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1.93 ± 0.70°C using the echo with the least uncertainty (TE=9.1 ms) (p<0.01 when 
compared to CSI with lipid as a reference). 
Table 5-3  Measured PRF, T2* and amplitude values with associated uncertainties for water, bulk 
methylene, terminal methylene and methyl protons using a four-peak model at 19 °C    
 
Chemical Shift PRF (ppm) T2* (ms) Amplitude (Normalized) 
Water 4.6856 ± 0.0091 56.2 ± 8.9 0.575 ± 0.054 
Bulk Methylene 1.1856 ± 0.0074 9.5 ± 0.2 1.000 ± 0.014 
Terminal Methylene 2.0285 ± 0.0044 3.6± 0.4 0.297 ± 0.014 
Methyl 0.8631 ± 0.0153 18.1 ± 0.7 0.369 ± 0.062 
 
Peaks were identified in the expected locations (155).  The water T2* is within range of previous T2 
measurements in bone marrow (156). 
 
Table 5-4  Measured PRF temperature sensitivity coefficients from multiple protons at 3.0T   
Chemical Shift                TSC [ppm/°C] (R2)   
Water -1.03x10-2 ± 1.4x10-4 (0.978) -1.28x10-2 ± 2.3x10-4 (0.981) 
Bulk Methylene -0.15x10-2 ± 0.9x10-4 (0.904) -0.42x10-2 ± 3.1x10-4 (0.972) 
Terminal Methylene -0.19x10-2 ± 2.7x10-4 (0.211) -0.44x10-2 ± 4.4x10-4 (0.487) 
Methyl -0.70x10-2 ± 3.1x10-4 (0.618) -0.84x10-2 ± 4.7x10-4 (0.816) 
Water – B. Methylene -0.88x10-2 ± 3.0x10-4 (0.917) -0.86x10-2 ± 2.3x10-4 (0.964) 
  
As with the 1.5T calibrations, the difference between the water and bulk methylene PRFs are consistent to 
literature (45, 53).  Temperature sensitivities of terminal methylene and methyl protons are also listed.   
 
Table 5-5 displays the TSC of each of the tissues along with the temperature 
range measured in the calibration.    All TSC are within the 95% confidence interval of 
what has been measured in soft tissue (-0.0097 ppm/°C with an exception of -0.0098 
ppm/°C for brain (157)).  In calibrations, where the temperature exceeded the break point 
for thermal damage, there were no shifts in linearity. 
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Table 5-5  Temperature sensitivity coefficients in various non-fatty tissues   
Tissue Type Temp. Range (ºC) 
Temp. Sensitivity 
(ppm/ºC) (R2) 
Brain 25-59 -0.0102 + 0.0005 (0.998) 
Prostate 32-59 -0.0099 + 0.0004 (0.995) 
Kidney 35-54 -0.0103 + 0.0006 (0.994) 
Liver 35-51 -0.0098 + 0.0002 (0.984) 
 
TSC values were within the expected values in soft tissues.  There were no shifts in linearity in the PRF.   
 Table 5-6 displays the RMSE and uncertainty of each tissue using CSI and CPD.   
CSI had lower RMSE and uncertainty compared to CPD which supports our hypothesis 
of greater precision and accuracy using the CSI technique. 
Table 5-6  Temperature accuracy and precision in various non-fatty tissues   
Tissue Type CSI RMSE (ºC) 
CPD RMSE 
(ºC) 
p-value CSI Unc. 
(ºC) 
CPD Unc. 
(ºC) 
p-value 
Brain 0.96 + 0.14 1.69 + 0.24 0.01 0.23 + 0.11 0.56 + 0.14 0.03 
Prostate 0.24 + 0.09 1.09 + 0.40 0.02 0.20 + 0.09 0.66 + 0.10 0.02 
Kidney 0.29 + 0.05 2.03 + 0.67 0.01 0.28 + 0.24 0.86 + 0.17 0.02 
Liver 0.58 + 0.16 1.25 + 0.10 <0.01 0.32 + 0.08 0.88 + 0.11 <0.01 
In support of our hypothesis, the accuracy and precision in temperature measurements in non-fatty tissues 
were statistically higher with CSI compared to CPD. 
5.3.3 DISCUSSION 
In calibration experiments at 1.5T and 3.0T in tissues containing lipid, PRF TSC 
values consistent with previous studies (43, 45) were observed when the difference 
between the water and bulk methylene PRFs are used for temperature estimation.  In fatty 
tissue, De Poorter et al. (43) measured an overall TSC of -0.0097 ppm/°C with a 
susceptibility constant of -0.0013 ppm/°C giving a corrected field shift of -0.0088 
ppm/°C, which is consistent with results reported here.   McDannold et al. (45) measured 
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similar TSC values in a mayonnaise-lemon juice phantom which was designed similarly 
to our phantom study.  As expected, using water PRF shift alone did not result in 
consistent temperature sensitivities due to varying degrees of susceptibility and drift 
between experiments.  For example, at 3.0T in bone marrow the water PRF was highly 
linear with temperature (R2=0.981).  However, its TSC was approximately 15-19% 
higher in one calibration than what was seen at 1.5T.  When the difference between the 
water and bulk methylene was taken to effect to correct for susceptibility, the TSC was 
measured as -0.0086 ± 0.0002 ppm/°C, within the 95% confidence interval of the 
measurements taken at 1.5T. Using the measured TSC by taking the difference between 
water and bulk methylene protons, we measured accurate temperature readings in each 
experiment (0.44 °C in phantom; 0.96 °C, 0.39 °C, and 0.54 °C in bone marrow at 1.5T; 
0.19 °C and 0.59 °C in bone marrow at 3.0T).  It is very important to note that this 
susceptibility effect on the temperature sensitivity of lipid-containing tissue is 
independent of whether or not lipids are suppressed.   In addition, although the RMSE 
and uncertainty were lower compared to single-echo CPD, one could reduce the 
acquisition time and/or bandwidth (to increase SNR) to improve accuracy and precision 
with CPD techniques.  This would not, however, account for susceptibility or field drift 
effects that were seen in the water PRF measurements.  
The phantom and bone marrow study exemplifies the advantage of having a lipid 
peak as a reference when relatively large susceptibility or field shifts occur.  There was 
no large susceptibility shifts seen in the non-fatty tissue in brain, prostate, kidney and 
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liver compared to the bone marrow.  This may be due to the interfaces in the cortical 
bone and the added susceptibility from the high lipid content in the marrow.   From these 
measurements, there appears to be an increased susceptibility effect from the presence of 
lipid which makes measurements difficult with CPD.     
To our knowledge, no MR thermometry study has investigated the temperature 
sensitivity of multiple lipid peaks simultaneously with this level of spatiotemporal 
resolution. It was found that although the terminal methylene peaks and methyl peaks 
could be resolved in bone marrow at 1.5T, the uncertainty was on the order of 0.03-0.08 
ppm making calibrations difficult to ascertain with confidence.  At 3.0T, each of the four 
peaks had sufficient SNR and spectral resolution for precise measurements so that the 
temperature dependence of each component of the lipid peak could be analyzed.  When 
using lipid for an internal, temperature independent, reference, highest accuracy and 
precision was demonstrated with bulk methylene for PRF-based reference thermometry.  
This was primarily due to a smaller uncertainty in the measurement and is likely due to 
the higher SNR of bulk methylene compared to the other lipid protons.   
In many lesions in fatty tissue, the primary component will be water, especially in 
the center of the lesion.  If no lipid is present, we expect high precision with temperature 
measurements as seen in our simulation outlined in chapter 4.  However, toward the 
borders of the lesion voxels may contain lipid.  It is important that lipid is taken account 
for in order to accurately measure the temperature, identify the borders of the ablative 
region, and verify if the entire lesion received an adequate thermal dose.   Also, 
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extrapolating the lipid field map into the lesion, much like what has been done with 
referenceless thermometry (158), could possibly be performed to improve temperature 
estimates in bone lesions and warrants investigation. 
As in our simulations, our phantom and ex vivo data support our hypothesis that 
this CSI technique provides higher precision and accuracy compared to the CPD 
measurements.  However, as seen in the bone study, it is important to identify the peaks 
correctly in order to apply the appropriate TSC.  The next chapter will address this by 
evaluating an algorithm which identifies water and lipid peaks and maps their spectral 
parameters to aid in improving temperature imaging. 
 
5.4 Multi-Parametric Analysis in Ex Vivo Tissue 
5.4.1 MATERIALS AND METHODS 
Canine bone marrow, brain, kidney, liver and prostate tissue were treated with a 
water-cooled applicator housing a 980-nm laser fiber with a 1-cm diffusing tip powered 
by a 15 W diode laser source (BioTex Inc., Houston, TX) on clinical MR scanners at 
1.5T (Excite HD, GE Healthcare, Waukesha, WI) and 3T (TwinSpeed Excite HD, GE 
Healthcare, Waukesha, WI).  A fluoroptic temperature probe (M3300, Luxtron, Santa 
Clara, CA) was inserted in order to provide an absolute measurement of temperature.  In 
each ablation, the MGE acquisition was used (1.5T: ETL=16 echoes; minimum TE 
(TE0)=2.0 ms; ESP=3.2 ms; TR=69 ms; FA=30-40°; rBW=244 Hz/pixel, acquisition 
matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image; parallel imaging 
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acceleration factor=2. 3T: TE0=2.1 ms; ESP=1.8 ms; rBW=325 Hz/pixel).  Echoes were 
acquired with unipolar gradients separated by flyback rewinder gradients.  ROIs (2 x 2 
voxels) were chosen in areas that reached ablative temperatures (≥54 °C) with each pixel 
processed individually.  Using the calculated TSC values from water (and bulk methylene 
PRF, if present, as an internal reference), the changes in the PRFs were converted to 
temperature changes and added to the baseline temperature provided by the fluoroptic 
temperature probe; thereby providing absolute temperature readings.  
In at least five ROIs in each tissue type, the water R2* was measured.  As will be 
shown in the results, each plot of R2* displayed an inflection point.  Blinded by the 
temperature and thermal dose data, data points were labeled as 0 before the inflection 
point and 1 after the inflection point with respect to time on the R2* plot.  The inflection 
point was defined as the point after a local maximum or minimum R2* with five 
consecutively decreasing or increasing values after the local maximum or minimum.  
Next, binomial logit analysis was used to fit the data as a function of thermal dose.  The 
probability, P, of the logit curve is defined as  
      
1
1
P
eα β+ Ω
=
−
                                 (5.1) 
where α and β are coefficients determined by the fit.   
The dose was calculated from the Arrhenius rate model for thermal damage where  
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0
aEt
RTAe dτ τ
−
Ω = ∫      (5.2) 
A is the frequency factor, Ea is the activation energy, R is the universal gas constant 
(8.315 JK-1mol-1)  and T(τ) is the temperature in degrees Celsius as a function of time, τ 
(26).  A and Ea values were chosen to predict protein denaturation (A: 3.1 x 1098 s-1, Ea: 
6.3 x 105 J mol-1) (25).  Ω≥1 signified tissue damage and this threshold has been used in 
previous studies (159, 160).  The dose was recorded where the probability of the fit 
equaled 0.5 (also known as LD50).  The fraction of damage cells (C(τ)/C(o), equation 
1.4) was also calculated.  The purpose of this measurement was to characterize the signal 
change as a function of thermal dose to determine if the changes occurred where damage 
was expected to occur.  The slopes of lines were measured before and after the inflection 
point with respect to temperature and compared using a two-tailed Student’s t-test with 
equal variances (as determined by an F-Test). 
5.4.2 RESULTS 
Figure 5-6 displays the logit fits for each of the tissues along with a logit fit for all 
the tissues combined.  Table 5-7 also shows the LD50 with uncertainty.  In each case, an 
Ω of 1 was within the 95% confidence interval for LD50.  In the formulism by Henriques 
(25), this value was used to signify irreversible damage by protein denaturation.   
113 
 
 
Figure 5-6 Logit fits for bone marrow, brain, liver, prostate and kidney tissue 
Using binomial logit analysis, the probability of 0.5 that a R2* change occurred were at thermal dose values 
known to cause irreversible damage as shown by Henriques (25).  The black line is the logit fit.  The blue 
solid and dashed lines are the LD50 values and the standard error, respectively.  The circles are binary data 
points for the curve fitting.  Note that there are several binary points beyond Ω=2 (Range: 0-1.49x107).  N 
is the number of binary points.  This shows that the R2* changes are occurring where damage is expected to 
occur.  
Table 5-7  Measured LD50 values for various tissues with associated confidence intervals   
Tissue LD50 (Ω) 95% CI α (A.U.) β (A.U.) C(τ)/C(0) [1-exp(-ΩLD50)] 95% CI p-value
Bone 0.77 (0.47,1.07) -4.18 ± 1.09 5.41 ± 2.23 0.54 (0.37,0.66) 0.03
Brain 1.10 (0.92,1.27) -3.20 ± 0.50 2.91 ± 0.72 0.67 (0.60,0.72) <0.001
Liver 0.85 (0.62,1.08) -6.40 ± 1.05 7.56 ± 2.11 0.57 (0.46,0.66) 0.01
Protate 0.97 (0.83,1.11) -3.50 ± 0.60 3.61 ± 0.95 0.62 (0.56,0.67) <0.001
Kidney 1.07 (0.92,1.22) -2.73 ± 0.35 2.55 ± 0.52 0.66 (0.60,0.70) <0.001
Combined 1.01 (0.94,1.08) -3.26 ± 0.25 3.24 ± 0.37 0.64 (0.61,0.66) <0.0001
 
The dose threshold of Ω=1.0 was within the 95% confidence interval for each tissue.  C(τ)/C(0) represents 
the fraction of cells that are damaged.  The p-values calculated from the logit fit shown that the fits were 
statistically significant in each case.   
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As an example of the signal change in lipid tissue, the R2* values and signal 
amplitudes of water and each lipid in bone marrow were plotted along with the Arrhenius 
rate estimate for irreversible tissue damage as a function of temperature in Figure 5-7.  
The slope between 17 °C and 54 °C was 2.8 ± 0.1 %/°C (R2=0.965).  At 54 °C and above, 
the slope was -1.6 ± 0.2 %/°C (R2=0.917).  Each of these slopes were statistically 
different from one another (p<0.0001).  For bulk and terminal methylene there is an 
asymptotic decrease in R2* until Ω approached unity.  There was also a change in the 
methyl R2* slope as Ω approached unity.  In the amplitude measurements, a shift in the 
slope can be observed in the water peak.  At temperatures where Ω <1, the slope was 0.4 
± 0.1 %/°C (R2=0.824).  At temperatures where Ω ≥1, the slope was -1.0 ± 0.2 %/°C 
(R2=0.905).  In the lipid peaks, the temperature response reduced in the bulk methylene, 
terminal methylene and methyl peaks by 75%, 88% and 80%, respectively, at the same 
temperature region. 
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Figure 5-7 Temperature response water R2* (a) and amplitude (b) as well as the lipid R2* (c) and 
amplitude (d) of bone marrow at 3.0T 
 The dashed line in each plot represents the Arrhenius dose model calculation (A: 3.1 x 1098 s-1, Ea: 6.3 x 
105 J mol-1) (25).  Changes in the slope can be seen when the Arrhenius dose, Ω, approaches 1.0, which 
signifies damage to the tissue. 
 
Figure 5-8 demonstrates what was typically seen in non-lipid tissue.  This is a 
case from brain tissue.  Table 5-8 lists temperatures where the break points occurred 
according to Arrhenius rate model analysis along with the slopes between these 
temperatures.  In all tissues except prostate, there was a statistically significant 
(p<0.0001) change in the R2* slope when damage is predicted to occur.  This was more 
evident when compared to the amplitude slopes.  
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Figure 5-8 The water R2* (a) and amplitude (b) temperature response of brain tissue at 3.0T   
As with the bone marrow, changes in slope can be seen when Ω approaches 1.0.  The break points in the 
parameters were seen at 57.1 ± 1.2 °C.  This corresponds to temperatures where phase changes are seen in 
the protein state.   
Table 5-8  Temperature break points (Ω >1) with linear regression slopes above/below these points. 
                                 R2* Slope (%/°C)        Amplitude (%/°C)
Tissue Temperature at Ω=1 37 ° to Break Point (BP) Above BP 37 °C to BP Above BP
Bone 54.2 ± 1.2 2.8 ± 0.1 %/°C (R2=0.965) -1.6 ± 0.2 %/°C (R2=0.917)** 0.4 ± 0.1 %/°C (R2=0.824) -1.0± 0.2 %/°C (R2=0.905)**
Brain 57.1 ± 1.2 5.5 ± 0.4 %/°C (R2=0.945) -4.3 ± 0.6 %/°C (R2=0.792)** -0.4 ± 0.1 %/°C (R2=0.799) -1.0 ± 0.2 %/°C (R2=0.803)*
Liver 52.2 ± 0.4 0.7 ± 0.3 %/°C (R2=0.852) -1.2 ± 0.1 %/°C (R2=0.894)** -0.8 ± 0.3 %/°C (R2=0.874) -0.9 ± 0.2 %/°C (R2=0.924)
Prostate 57.0 ± 1.0 0.2 ± 0.1 %/°C (R2=0.872) 0.4 ± 0.1 %/°C (R2=0.565) -0.4 ± 0.2 %/°C (R2=0.851) -0.5 ± 0.1 %/°C (R2=0.944)
Kidney 57.0 ± 0.4 2.1 ± 0.5 %/°C (R2=0.625) -1.0 ± 0.4 %/°C (R2=0.717)** -0.7 ± 0.3 %/°C (R2=0.823) -0.7 ± 0.1 %/°C (R2=0.857)
 
* p<0.05,** p<0.001 compared to slope before the break point 
5.4.3 DISCUSSION  
 With this fast CSI technique, other parameters (peak-specific R2* (1/T2*) and T1-
W amplitude) can also be measured to provide an important opportunity to look at 
changes as a function of temperature.  Estimated spectral parameters were evaluated as a 
function of the higher temperatures that would be encountered during ablative therapy 
delivery using the calibrated PRF shift of water-bulk methylene or water alone.  It is 
important to note that we did not see changes in linearity in the PRF at high temperatures 
(see Figure 5-4), which is consistent to previous studies where high linearity was found 
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up to 80 °C (37).  In this analysis, we did see changes in linearity of R2* and amplitude 
data during heating (60, 72).   We have previously noted significant changes in the 
temperature dependence of these parameters in the range where the Arrhenius rate model 
predicts damage (25, 26) thereby demonstrating that it could be a useful dosimetry tool.  
For example, when the temperature history results in Ω≥1, there was a consistent, sharp, 
measureable change in the slope of the R2* of water versus temperature.   
The molecular mechanisms for these changes are not exactly clear and 
understanding the relationship between the dynamics and structure of proteins and the 
surrounding water is a current challenge (161).  Possible theories to these changes due to 
the protein denaturation include the change in the dipolar coupling between water 
molecules and denatured proteins (162).  Additionally, release of water in the hydration 
layers of the denaturing proteins may explain the decrease in R2* (161).     
Water and lipid R2*-corrected amplitudes also exhibited similar non-linearities in 
the same temperature ranges as seen in Figure 5-7 and 5-8.  These changes were more 
evident than measuring changes in the overall T1-W signal (from the first echo of the 
acquisition), which has also been shown here and previously to be non-linear with 
temperature in this range, presumably due to irreversible protein conformation changes 
(72).  It is important to note that these changes in slopes were seen with and without R2* 
correction over physiologically relevant temperatures (37 °C and above).   
Therefore, it appears that using the multiparametric spectral estimates may return 
information on physical tissue changes taking place, such as conformational phase 
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transitions of proteins, which directly influence the proton chemical macroenvironment 
and, thereby, relaxation as observed in R2* mapping and T1-W signal changes.  These 
observations warrant further investigation in vivo and in other tissues, particularly in the 
presence of heat sensitization agents which might be used to lower the therapeutic 
window as direct validation of protein denaturation and it may be extremely useful in the 
investigation of thermal approaches to ablation as well as drug delivery or enzyme 
activation.   
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Chapter 6: Spectral Parameter Mapping with the k-
Means Clustering Algorithm 
6.1 Introduction 
As seen in the previous chapter, the CSI technique accurately and precisely 
determines the PRF, T2* and amplitude of each peak.  These parameters can be inputs 
into the k-means algorithm to help distinguish peaks since each spectral peak will be 
differentiated by at least the PRF and the other parameters may aid in improving the 
sensitivity and specificity of peak identification for 2D mapping of temperature for 
interventions.  The algorithm will be explained and parameters will be tested using a 
highly-controlled mathematical phantom.  After suitable parameters are found, they are 
used in the analysis of data from several ex vivo and in vivo tissues. 
6.2 Processing Strategy  
First, the image is partitioned to equal-sized regions (4x4, 16x16, 32x32 voxels, 
etc.).  In each voxel in the regions, the primary PRF, T2* and amplitude values are 
mapped to a 3D plot where T2* values and amplitudes are normalized.  The centroid of 
all the points in the plot is then calculated as well as the sum of distances between the 
points and the centroid.   The same calculations are made again using 2 centroids via the 
k-means algorithm.  If the sum of distances are less with the two centroids and the 
centroids are at distances apart where water and lipid is expected to be (3.3-3.8 ppm), 
then the clusters are designated water or lipid (see Figure 6-1).  This process continues 
for each region in the image.   
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After the entire image is processed, the ranges of water and lipid centroids are 
recorded.  On the frequency axis in the 3D plot, the range of PRFs is expanded by a 
constant, g, to account to regions experiencing slightly higher or lower magnetic flux 
densities.  Each voxel is then recalculated using a 2-peak ARMA model.  If both peaks 
fall within the PRF regions, then the spectral parameters are mapped.   Expansions on T2* 
and amplitude values were not utilized since these values can vary due to relative 
concentration of each chemical specimen.  Finally, any voxel remaining was calculated 
with a 1-peak ARMA model with peak identification determined by the PRF and T2* 
ranges described above.   Figure 6-1 shows a schematic of how the algorithm works on a 
mathematical phantom, which is described in the next section. 
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Figure 6-1 Mapping using k-means 
The image is separated into regions.  First, regions that contain both water and lipid are located.  The 
spectral information from those areas is used to train the algorithm to look for primary and secondary peaks 
to create maps of each chemical specimen.   
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Figure 6-2 Representation of two regions analyzed by the k-means algorithm using the mathematical 
phantom – step 1 
The red region represents an area with water only.  The green region contains water and lipid.  When the 
centroid is calculated from the primary peaks, the sum of distances between the data points and the centroid 
can aid in determining if one or two peaks are present.  Frequency expansions can be added to increase the 
range of PRF values the algorithm will seek for primary and secondary peaks.   
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6.3 Testing of the CSI k-means Clustering Algorithm Using a 
Mathematical Phantom 
6.3.1 MATERIALS AND METHODS 
To test the algorithm in highly controlled conditions, a mathematical phantom 
was developed in MATLAB (MathWorks, Natick, MA) and is shown in Figure 6-3.  In 
the phantom, areas of water, lipid and mixed water/lipid were created within different 
sized regions.  Large areas of each water/lipid combinations were also created to 
determine how the algorithm handles large areas of only one chemical shift, which is 
commonly seen in vivo.   
 
Figure 6-3 Mathematical phantom design 
The phantom contains areas of water, lipid and mixed water/lipid voxels under varying sizes.  The phantom 
was designed to work under varying areas of water and lipid. 
Three metrics were used to measure the performance of the algorithm.  If a peak 
was identified in the voxel then the voxel is counted as positive.  If no peak is identified 
then the voxel is counted as negative.  The sensitivity of identifying the correct peak was 
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defined as the true positive rate (tested positive/ true positive).  Specificity was defined as 
the true negative rate (tested negative/ true negative).  The Dice similarity coefficient 
(DSC) (163) was also used.  Given two images, A and B, where A is the true image and B 
is the measured image, the DSC is the metric of how the two images overlap where 
BA
BA
DSC
+
∩
=
2
     (6.1) 
 The sensitivity, specificity, and DSC were measured as a function of field 
inhomogeneity across the FOV, size of the regions, expansion in the frequency axis on 
the 3D plots and SNR.   Each mapping experiment went through 5 trials.  The field 
inhomogeneity was incorporated into the phantom spatially by multiplying the signal by a 
complex exponential that smoothly varied as a function of position on the x-y plane.  The 
field inhomogeneity was measured from 0.2 to 4.0 ppm.  Region sizes by powers of 2 (4, 
8, 16, 32, 64, 128) were measured at a field inhomogeneity of 1.13 ppm and a frequency 
expansion of 0.1 ppm.  Frequency expansions up to 1.0 ppm were evaluated at the same 
SNR at a 1.13 ppm field inhomogeneity.  When suitable frequency expansions and region 
sized were determined, the sensitivity, specificity and DSC were measured as a function 
of SNR.    
6.3.2 RESULTS 
Figure 6-4 displays the sensitivity, specificity, and DSC as a function of field 
inhomogeneity across the entire FOV for the water and lipid maps.  The specificity and 
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DSC for water and lipid was greater than 0.999 up to a field inhomogeneity of 1.42 ppm.   
Sensitivity measurements for the water and lipid maps were above 0.999 up to 2.83 ppm.   
 
Figure 6-4 Sensitivity, specificity and DSC results as a function of field inhomogeneity 
Both water and lipid maps maintained high sensitivity (>0.999) up to a field inhomogeneity in the FOV to 
2.83 ppm.  Specificity and DSC values for each peak were at the same high values to 1.42 ppm.  Each 
measurement decreased at higher field inhomogeneities.   Error bars were on the order of 0.001 so they 
were not shown on the figure.   
  
The size of the regions used in algorithm appears to have an effect on the 
sensitivity, specificity and DSC.  Figure 6-5 shows the values for water and lipid as a 
function of region sizes.  As seen in this figure, sizes between 8x8 to 16x16 maintained 
high sensitivity, specificity and DSC values.  Under 8x8 voxels, errors occurred in the k-
means algorithm due to a low number of data points.   
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Figure 6-5 Sensitivity, specificity and DSC results as a function of region size 
High sensitivity, specificity and DSC values were measured at regions sizes of 8x8 and 16x16.  At higher 
region sizes each metric decreased in value.  Most errors at these larger region sizes stemmed from 
misidentified regions of after the range of PRF values were identified.  A lower number of water and lipid 
centroids increased the likelihood that peaks were identified due to a lower-sampled range of values.  The 
k-means algorithm still separated out the peaks effectively as outlined in Figure 6-3.  In this figure the field 
inhomogeneity was 1.13 ppm. 
 
 At 0.1 ppm and above, the sensitivity, specificity and DSC values of the maps 
were highly linear with the amount of frequency expansion allowed as shown in Figure 6-
6.   Using linear least-squares regression analysis, the water specificity and DSC curves 
were -0.0499 ± 0.0003 ppm-1 + 0.9984 ± 0.0018 (R2=0.9497,) and -0.0061 ± 0.0002 ppm-
1
 + 0.9998 ± 0.0007 (R2=0.9501), respectively.  The sensitivity was measured as 1.0 from 
0.1  to 1.0 ppm.   Interestingly, the sensitivity at ppm=0 was 0.719 ± 0.001 showing that 
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some voxels containing water were missed if no frequency expansion was used.  For the 
lipid maps, the specificity and DSC curve fits were  -0.0778 ± 0.0005 ppm-1 + 0.9977 ± 
0.0024 (R2=0.9973) and -0.2067 ± 0.0008 ppm-1 + 0.9774 ± 0.0037 (R2=0.9993),  
respectively.  From 0 to 1.0 ppm, the sensitivity of the lipid map was above 0.998 even 
when there was no frequency expansion.   
 
Figure 6-6 Sensitivity, specificity and DSC results with a frequency expansion in the 3D plots 
Sensitivity was not affected as long as there was some expansion in the frequency axis to look for voxels 
that had PRF values outside of the range the algorithm calculated in regions with water and lipid.  In the 
maps, if g=0, then some water voxels were missed since their PRF values lied just outside the range which 
was calculated in the image.  However, as g increases then the specificity and DSC decrease.  In this plot, 
the field inhomogeneity was 1.13 ppm with a 16x16 region size.   
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 Figure 6-7 shows the sensitivity, specificity and DSC as a function of SNR.  As 
SNR increases, each metric asymptotically approached 1.0.  At SNR≥10, each parameter 
was at 0.95 or above.   For mapping of two chemical shifts, a SNR of 10 and above 
should produce high sensitivity and specificity.  For this plot, there was a field 
inhomogeneity of 1.13 ppm with a 0.1 ppm frequency expansion.   
 
Figure 6-7 Sensitivity, specificity and DSC results at low SNR 
The DSC values and sensitivity of the mapping algorithm asymptotically approached 1.0 at a SNR of 
approximately 10.  Specificity was high even at low SNR of 5.  SNR values of 10 and above are sufficient 
for sensitive and specific mapping under moderate field inhomogeneity (~1.0 ppm).   
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 Table 6-1 summarizes how each parameter affects the sensitivity, specificity and 
DSC of the mapping algorithm.  It can be noted that each parameter, with the exception 
of the frequency expansion, approaches unity as the limit approaches zero (field 
inhomogeneity, region size) or infinity (SNR). 
Table 6-1  Parameter dependence on the algorithm’s sensitivity, specificity and DSC 
Parameter Change  Sensitivity Specificity DSC 
Field Inhomogeneity  ↑ ↔ then ↓ ↔ then ↓ ↔ then ↓ 
Region Size ↑ ↔ then ↓ ↔ then ↓ ↔ then ↓ 
Freq. Expansion ↑ ↔ ↓ ↓ 
SNR ↑ ↑ then ↔ ↑ then ↔ ↑ then ↔ 
 
Most parameters showed an asymptotic behavior toward unity as the parameter approached zero or infinity.  
Generally, a low field inhomogeneity, region size and frequency expansion with high SNR is near-optimal 
conditions for the k-means mapping algorithm. 
 
6.4 Demonstration of the k-means Mapping Algorithm in an In Vivo 
Swine Liver Model 
6.4.1 MATERIALS AND METHODS 
To test this algorithm with a near-realistic clinical scenario of a liver ablation, the 
MGE acquisition was utilized on swine being examined in a MR protocol study.  The 
animals used in this study were handled in accordance with the Institutional Animal Care 
and Use Committee.  For each pig, three axial slices were obtained through the liver (16-
echoes, TR/TE0/ESP=500/1.8/3.0 ms, flip angle=45, receiver bandwidth = 244 
Hz/pixel, acquisition matrix = 128 x 128, acceleration factor = 2, voxel size = 1.6 x 1.6 x 
4.0 mm3, acquisition time = 32 s). 
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Based on our simulation results, region sizes of 16x16 voxels were used with a 
frequency expansion of 0.1 ppm.  The PRF, T2* and amplitude were all input parameters 
for the k-means cluster analysis.  Images where then qualitatively compared to lipid-
water images generated using a two-point, region growing, Dixon technique (FSPGR, 2-
echoes, TR/TE1/TE2=175/1.8/4.3 ms, flip angle=80, receiver bandwidth = 244 
Hz/pixel, acquisition matrix = 256 x 224, acceleration factor = 2, voxel size = 1.3 x 1.3 x 
8.0 mm3, acquisition time = 22.4 s/image) (135).  Note that there was a difference in 
spatial resolution between this technique and two-point Dixon technique which made 
direct, quantitative, voxel by voxel comparisons difficult to ascertain.  There was also 
breathing between the two acquisitions which also makes voxel-based comparisons 
difficult.  Therefore, the generated images were qualitatively examined based on accurate 
mapping of known lipid-water tissues as well as the algorithms performance as predicted 
by simulations. 
6.4.2 RESULTS 
Figure 6-9 displays images processed by our technique with comparison to the 
Dixon-processed images.  PRF, T2* and amplitude maps were created of water and lipid 
(bulk methylene).  Note that the Dixon technique identified intra-peritoneal organs (liver, 
stomach, spleen) as lipid.  Using the MGE acquisition incorporated with the SM and k-
means algorithms the organs were correctly mapped into the water image.  One error seen 
in our mapping routine is an area of susceptibility on the anterior portion of the spleen.  
Figure 6-10 displays an axial slice where the k-means algorithm and Dixon technique 
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matches well.  Motion between the two scans limited the ability for quantitative 
comparison on a voxel-by-voxel basis.   
 
 
Figure 6-8 CSI mapping in porcine in vivo with artifact in Dixon imaging 
PRF, T2* and amplitude maps of lipid and water were created using the MGE acquisition with the SM and 
k-means algorithm.  In addition, a Dixon-based method using a robust region-growing algorithm is shown 
(135).   In this axial slice, the liver, spleen and stomach were mapped to the lipid image.  The k-means 
algorithm correctly mapped these organs to the appropriate water image.  Three slices were collected and 
the Dixon technique mapped the organs to the appropriate map as did the k-means algorithm. 
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Figure 6-9 CSI mapping in porcine in vivo 
PRF, T2* and amplitude maps of lipid and water using the MGE acquisition with the SM and k-means 
algorithm in addition to Dixon-based lipid-water images.  Qualitatively, there is good agreement between 
the two types of processing paradigms.  Quantitative voxel-based measurements using Dixon as the true 
standard was not possible due to respiratory-based motion between the scans.  Some errors can be seen in 
the k-means approach inside the stomach presumably due to low SNR. 
 
 Figure 6-10 presents an example where our simulations predicted lower 
specificity and DSC due to field inhomogeneity, which led to the misidentification of 
liver tissue as lipid.  At the interface between the liver and subcutaneous tissue there was 
a measured field inhomogeneity of approximately 1.8 ppm. As seen in Figure 6-5, there 
should be lower specificity (i.e., fewer true negatives) in the water map, which is seen in 
Figure 6-10.  From the errors introduced from this field inhomogeneity areas with similar 
magnetic flux densities as liver (i.e., skin) was also incorrectly mapped as lipid.  This 
shows that although efficient mapping is possible, certain conditions can affect the 
efficacy of the algorithm.  
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Figure 6-10 Effects of high field inhomogeneity in vivo 
A 1.8 ppm field shift was measured between the liver and muscle just posterior to the liver.  This 
inhomogeneity caused lower specificity between distinguishing water and lipid in CSI images as predicted 
by our simulation.  The Dixon method correctly identified the liver as water-based tissue in contrast to 
Figure 6-8.   
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6.5 Demonstration of Thermal Therapy in Brain In Vivo 
6.5.1 MATERIALS AND METHODS 
We examined the feasibility of using the multi-parametric nature of the technique 
for guiding MR thermal therapy interventions in a large animal model by using the MGE 
acquisition to guide the application of laser induced thermal therapy in a canine brain in 
vivo using a 1.5T scanner.  The animal used in this experiment was handled in 
accordance with Institutional Animal Care and Use Committee requirements.  A water-
cooled applicator containing a laser fiber (Biotex Inc., Houston, TX) with a 1-cm 
diffusing tip (808 nm) was inserted into the right hemisphere of the canine brain using 
MR guidance.  Treatment was delivered using an exposure of 3.5 W/cm2 for 180 seconds 
under continuous MGE monitoring (16-echoes, TR/TE0=69 ms/2.1 ms, flip angle=30, 
receiver bandwidth = 244 Hz/pixel, acquisition matrix = 128 x 128, acceleration factor = 
2, voxel size = 1.6 x 1.6 x 4.0 mm3, acquisition time = 4.4 s/image).  The ESP was 3.3 
ms, giving a spectral bandwidth of 303 Hz.  Using the PRF map from the SM algorithm, 
the shift in the PRF was measured to detect temperature changes (37) using a temperature 
sensitivity of -0.0098 ppm/°C (157).  In addition, T2* maps and T2*-corrected T1-W 
images (signal extrapolated to TE=0 ms) were created from the data and analyzed to 
demonstrate the potential usefulness. 
6.5.2 RESULTS 
The MGE acquisition (ETL=16) with SM algorithm processing was applied to 
monitor a laser-induced thermal therapy in canine brain in vivo.  Figure 7(a) shows the 
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water proton field map, which is the source of the temperature images, and Figigure 7(b) 
displays the temperature map.  The SM algorithm calculated the noise in the temperature 
map as 0.34 ± 0.09 °C in an unheated region contralateral to the therapy site.  This is in 
excellent agreement with the calculated CRLB (SNR=39.5, T2*=42.0 ms) of 0.35 °C.  
Using the CPD of a single echo from the same acquisition at TE= T2* (which is the 
optimal value for CPD), the uncertainty approximately doubled to 0.69 ± 0.18 °C (p<0.01 
when compared to CSI).  Unlike the CPD technique, the sensitivity of the CSI technique 
is inherently driven by the SNR of the acquisition and is independent of the echo-time 
used (apart from the impact on SNR).  Figure 7(d) is the T1-W image, corrected for T2* 
decay from our knowledge of the T2*, which was also calculated at each time point.  
During treatment delivery, an anomalous artifact arose in the temperature images that 
correlated with a hyperintense area seen near the laser source on the T1-W images.  This 
was suspicious for an acute hemorrhage induced by the treatment.  The suspected 
hemorrhage was confirmed by a post-treatment T1-W SPGR acquisition [Figure 7(e)].  
An image of the calculated T2* for water [Figure 7(c)] shows a clearly hypointense 
lesion.   
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Figure 6-11 Multi-parametric monitoring in LITT in canine brain in vivo  
The water PRF map of a canine brain used to create the temperature maps had a temperature sensitivity 
coefficient of -0.0098 ppm/°C (a). The temperature map for the thermal therapy in the canine brain (b). The 
noise calculated in an unheated region contralateral to the therapy site was 0.34±0.09 °C. Using CPD at 
TE=T2*, the uncertainty increased to a mean of 0.69±0.18 °C. A T2* map generated by the SM algorithm 
(c). The T1-W images with T2* correction simultaneously calculated at each acquisition along with the 
temperature maps (d). During treatment, a hyperintense area developed near the laser source, raising the 
suspicion of a treatment-induced hemorrhage (indicated by an arrow). The hyperintense lesion, clearly 
shown on (c), was confirmed as a treatment-induced hemorrhage on a posttreatment T1-W SPGR 
acquisition (e).  Reprinted with permission from the American Association of Physicists in Medicine, 
(150). 
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6.6 Demonstration of Thermal Therapy in Prostate In Vivo 
6.6.1 MATERIALS AND METHODS 
Laser-induced thermal therapy was performed in a canine prostate in vivo.  As 
with previous experiment, this experiment was approved by the Institutional Animal Care 
and Use Committee.   Two water-cooled interstitial lasers tuned to 980 nm (Biotex Inc., 
Houston, TX) were placed into the prostate from the anterior surface of the canine.  The 
anesthetized animal was placed in a 1.5T clinical scanner with a 12-channel torso coil.    
Treatment was delivered under continuous MGE monitoring (16-echoes, TR/TE0=69 
ms/2.1 ms, flip angle=30, receiver bandwidth = 244 Hz/pixel, acquisition matrix = 128 
x 128, acceleration factor = 2, voxel size = 1.9 x 1.9 x 4.0 mm3, acquisition time = 4.4 
s/image).  The ESP was 3.2 ms.  The SM and k-means algorithms were used to identify 
water and bulk methylene peaks to create temperature maps.  The precision of the 
temperature estimates were recorded using the CSI and CPD techniques (TE=24.5 ms).  
The mean time it took to process one acquisition was also recorded.   
6.6.2 RESULTS 
Using the k-means algorithm with the parameters found in the mathematical 
phantom analysis, lipid and water was adequately separated.  No lipid was found in the 
prostate itself so the differences in the water PRF map were multiplied by -0.0097 
ppm/°C to calculate temperature.  Using CSI, the uncertainty in the temperature map 
was 0.7 ± 0.2 °C whereas the CPD uncertainty was measured at 1.4 ± 0.3 °C (p=0.02).  
The time to process one acquisition was 33.2 ± 5.2 seconds. 
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Figure 6-12 Water, lipid and temperature maps in canine in vivo 
Water and lipid were separated which some error in the rectum due to susceptibility (air/tissue interfaces) 
and low SNR. The temperature maps were created using the difference of the water PRF map.  The noise in 
the CSI maps was roughly half of what was seen in CPD (0.7 ± 0.2 °C for CSI and 1.4 ± 0.3 °C for CPD 
(p=0.02)). 
6.7 Regional CSI for Real-Time Mapping 
6.7.1 MATERIALS AND METHODS 
To increase the temporal resolution while using computer processors which would 
make the processing easily accessible, a user-defined regional k-means algorithm was 
created.   The parameters and code is the same as in the full FOV algorithm.  However, 
with this algorithm the user defines a ROI to process that region alone.  Note that in 
interventions we are usually focused only on the area of intervention.   
The algorithm was tested on ex vivo bone marrow tissue as well as in vivo 
prostate.  These tissues represent some of the more difficult areas to map due to 
heterogeneous lipid and water content.  Mapping was done using data from laser-induced 
thermal treatments on ex vivo bone which was previously described in section 5.3.1.  The 
difference between the fluoroptic probe readings and CSI or CPD readings were also 
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measured.  Temperature was calculated using bulk methylene as an internal reference (-
0.0087 ppm/°C).   
In another canine, treatment was delivered using an endorectal high-intensity 
focused ultrasound (HIFU) device (Insightec, Inc., Hefei, Isreal).  Again, in a 1.5T 
scanner, monitoring was done under continuous MGE acquisitions (16-echoes, 
TR/TE0=69 ms/1.9 ms, flip angle=30, receiver bandwidth = 244 Hz/pixel, acquisition 
matrix = 128 x 128, acceleration factor = 2, voxel size = 1.9 x 1.9 x 5.0 mm3, acquisition 
time = 4.4 s/image).  In order to run in real-time, the SM and k-means algorithms were 
adapted where processing could be performed in real-time (< 5 secs) by allowing the user 
to define a ROI to make the maps.  Water and lipid PRF maps were created in a region 
encompassing the prostate and times to process were recorded. 
6.7.2 RESULTS 
Figure 6-13 shows the mapping in a small ROI around the heating region in bone.  
Note that water and lipid were detected throughout the marrow parenchyma.  There was a 
low area of SNR due to the laser fiber placement which accounts for the voxels being 
absent in the center of the images.  A fluoroptic probe was in this specimen.  The RMSE, 
using the fluoroptic probe measurement as the true measurement, was 0.54 ± 0.13 °C for 
CSI and 1.75 ± 0.42 °C for CPD (p=0.04).  The uncertainty was measured as 0.68 ± 0.09 
°C using bulk methylene as an internal reference and the uncertainty was 1.98 ± 0.18 °C 
(p<0.01).   The time to process one acquisition was greatly reduced compared to full 
FOV processing at 4.3 ± 0.2 seconds, which is adequate for real-time guidance. 
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Figure 6-13 Water, lipid and temperature maps in canine bone marrow ex vivo 
Water and lipid were separated in the bone marrow. The temperature maps were created using bulk 
methylene as an internal reference.  As seen in the measurements in chapter 5, the RMSE was lower in CSI 
(0.54 ± 0.13 °C for CSI and 1.75 ± 0.42 °C for CPD (p=0.04)).   
 
Areas of water, lipid and mixed voxels were seen in the in vivo prostate images 
analyzed by the regional CSI algorithm.  As with the bone, image processing time was 
rapid at 4.7 ± 0.5 seconds per acquisition.  Figure 6-14 shows the water and lipid PRF 
maps as well as a map of where water and lipid is both present.  For verification, a FFT 
of voxels in each area were processed to confirm that there as indeed water and/or lipid 
peaks in those areas.   
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Figure 6-14 Water and lipid PRF maps in canine prostate in vivo 
Areas of water and lipid were identified and confirmed by processing spectra manually in each area.  One 
area of error found was in the rectal area under the prostate which is an area of low SNR.   
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6.8 Discussion 
The primary aim of the research described in this section was to take advantage of 
the wealth of multi-parametric data in order to provide robust mapping without requiring 
certain constraints (i.e., constant chemical shift between lipid and water, equivalent T2* 
between chemical shifts) which can affect the accuracy and precision of temperature 
mapping.    
In the post-processing of many CSI acquisitions, assumptions are made in order to 
map a certain parameter.  For example, in Dixon methods in addition to IDEAL (see 
section 3.4) there is typically an assumption that the chemical shift between water and 
lipid is constant.  This is used in order to image the amplitude to either look at water-only 
images or calculate the fraction of lipid in the image.  In PRF-based temperature imaging, 
the assumption of a constant chemical shift difference between water and lipid does not 
hold since the water PRF shifts with temperature.  This shift, particularly at high 
temperatures, can lead to errors in the image separation.  In addition, field maps are 
typically generated, which have been used to estimate temperature changes.  This, 
however, does not give an independent map of the lipid field in order to correct for 
susceptibility, field drift and motion.  
 The choice of the k-means algorithm for mapping is multi-faceted.  In addition to 
its known robustness in segmenting data it is computationally inexpensive, which is 
important since this needs to be implemented in near-real time for MR interventional 
procedures.  It can be parallelized in order to decrease the processing time.  The regional 
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processing method presented can also be implemented since in interventional procedures 
the site of the intervention is the primary point of interest and not the entire image. 
The purpose of the mathematical phantom studies was to provide a highly-
controlled setup in order to test the performance of the algorithm.  From these 
simulations, we were able to choose appropriate parameters, such as PRF ranges and 
region sizes, to increase the sensitivity and specificity of the technique.  Also, it was very 
useful to determine extrinsic (algorithm-based) and intrinsic (subject-based (SNR, 
inhomogeneity) parameters to show when the algorithm will fail.  As an example, Figure 
6-11 showed a misidentification of liver tissue as lipid.  This was caused by field 
inhomogeneties which were shown to have lower specificity as seen in Figure 6-4.  In 
this case, the large field inhomogeneity was highly localized to areas around the liver, 
which will make it difficult to properly map.  In situations with field inhomogeneities 
across the FOV, the image can easily be separated into 2-4 images in which each image 
will presumably have a lower field inhomogeneity.  This should work as long as lipid and 
water is present in each section of the image. 
Our in vivo data in the canine brain highlight some of the potential advantages of 
multi-parametric monitoring for thermal therapy procedures because both physiologic 
(temperature) and anatomic (T1-W, T2* maps) information are available.  In this case, a 
treatment-induced hemorrhage was monitored during treatment.  In CPD techniques, the 
optimal echo time is given by the T2* of the signal (38).  Magnitude images are, 
therefore, contaminated by the T2*-weighting of the signal (exp(-TE/T2*)) which can 
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obscure T1 changes in the image.  This would make it difficult to observe the hemorrhage 
and, more importantly, determine when it occurred during treatment.  The T2* correction 
with this technique allowed us to view a T1-W image at effectively TE=0, which, in this 
case, allowed visualization of hyperintensity that was not seen on the magnitude images 
at TE=T2*.  This example shows that this technique can be performed in vivo and shows 
increased precision compared to CPD.  Accuracy in each in vivo experiment could not be 
measured due to the lack of an invasive temperature probe in the heated region.   
One of the challenging areas in which to map the PRF is in bone marrow.  Figure 
6-13 demonstrates the ability to accurately and precisely measure the temperature in these 
areas.  Currently, CPD-based MRTI is a challenge due to heavy lipid content.  As seen in 
the PRF calibrations, this CSI technique is particularly useful in lipid-containing tissues 
in addition to tissues with no lipid, such as brain and kidney.  The method is also useful 
to map lipid around the prostate, which may be used to approximate the field in the 
prostate.   
 
 
 
 
 
145 
 
Chapter 7: Conclusions and Future Directions 
7.1 Concluding Remarks 
Robust spectral processing and mapping algorithms have been developed, 
validated and applied to a MGE acquisition in order to provide CSI-based temperature 
imaging at higher spatiotemporal resolutions than what was previously available.  In 
previous techniques, the acquisition and processing strategies were limited by avoiding 
spectral aliasing and by collecting enough samples to implement Fourier-based analysis 
as seen in high spectral resolution CSI (45-47).  This degrades the spatiotemporal 
resolution by requiring interleaved shots, especially at 3.0T, to reduce the echo-spacing.  
A high number of samples (32 or higher) also requires a longer acquisition time.  In 
addition, receiver bandwidths are raised which reduces the SNR, and thus sensitivity, of 
the technique (45-47).   
After investigating the limitations of filtered Fourier methods, we researched 
alternative methods to accurately and precisely determine the spectral parameters from a 
low number of samples that could be translated into a rapid CSI acquisition.  The ARMA 
model was deemed as an appropriate model since, unlike Fourier techniques, accounts 
not only for the PRF but also relaxation and noise.  By incorporating this model, PRF, 
T2* and amplitudes were measured accurately and precisely over a wide range of ETL 
and SNR values.   
Another important contribution in this investigation was the incorporation of the 
CRLB not only to validate the model but also to use it to theoretically determine the 
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sensitivity as a function of extrinsic and intrinsic acquisition parameters.  Using CRLB 
analysis, it was found that the sensitivity depends on more parameters than what is seen 
in CPD techniques (equations 4.2-3).  Unlike another CRLB derivation for PRF-CSI, 
which looks only at the precision of the temperature estimate using lipid as a reference 
(164), this CRLB analysis provides theoretical estimates of the PRF as well as T2* and 
amplitudes for each peak in the spectra.  Details on the CRLB can be found in Appendix 
A.  In both one-peak and two-peak models, measured uncertainties in phantom, ex vivo, 
and in vivo tissues agreed well with what was predicted by the CRLB. 
Another important finding in the ARMA approach was the remarkable precision 
and accuracy even when the number of peaks in the model is underestimated.  This 
appears to be due to the analysis being performed in the z-domain.  The information is 
concentrated in poles in z-space, as seen in Figure 7-1.  When one peak is chosen for the 
model, the algorithm gravitates to the dominate peak thus giving an accurate estimate for 
that peak.     
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Figure 7-1  Z plot using a one and two peak ARMA model 
The zeroes (o) and poles (X) for a one-peak (blue) and two-peak (red) ARMA model estimated by the SM 
algorithm.  A two-peak model was simulated.  When a one-peak model was applied to the simulated signal, 
the pole was calculated to be approximately where the two-peak model calculated to be.   This shows that 
even if the number of peaks is underestimated, the primary peaks are still calculated with high accuracy.   
Overall, in terms of the first specific aim of developing, validating and 
characterizing via simulation a model-based spectral analysis algorithm, we found that 
the SM algorithm provided higher precision compared to CPD (Figure 4-16) and high 
precision/accuracy (<1.0 °C) over a wide range of ETL and SNR values.   This is in 
support of our hypothesis. 
Using our CRLB analysis, we found that the SNR is directly proportional to the 
precision and accuracy of the spectral processing algorithm.  Thus, we investigated the 
acquisition parameters that maintain high SNR in addition to acquisition parameters to 
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avoid for accomplishing the goal of accurate and precise temperature imaging.  After 
several phantom experiments, we achieved the SNR that provided uncertainties that were 
predicted using our CLRB analysis as well as simulations.  Thus, we showed that the 
MGE acquisition can provide the SNR and parameters necessary to use the ARMA 
model for temperature estimation, which also supports our hypothesis.    
In tissues with multiple chemical shifts, it is very important to accurately identify 
the chemical shift in order to apply the correct, chemical shift-dependent, TSC for 
accurate temperature imaging.  By taking advantage of the multi-parametric data, we 
utilized a clustering algorithm with high sensitivity and specificity while maintaining 
reasonable processing times for real-time implementation.  This k-means algorithm has 
also been adapted to work with images across an entire FOV or in a smaller ROI defined 
by the user.   
With highly sensitive and specific mapping, we were able to measure temperature 
changes and TSC values in a variety of phantoms and tissues.  In cases where a 
temperature probe was used to compare between the CSI and CPD temperature estimates, 
the CSI method had statistically higher accuracy and precision, which supports our 
hypothesis.   
In addition to higher precision in non-fatty tissues, an important and interesting 
finding was the TSC measurements when bulk methylene was used as an internal 
reference.  If lipid is present in the tissue, the lipid susceptibility effect corrections are 
necessary in order to give more accurate measurements.  This is an important finding 
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when CPD is used in certain organs, such as breast, bone marrow and, in some cases, 
liver.  Basic suppression of lipid or selective excitation of water for PRF-based 
temperature measurements will not suppress the effects from lipid since water will still 
experience susceptibility from the lipid.  As seen in this work, correcting for the 
susceptibility by using lipid as a reference provides higher accuracy and should be 
considered when monitoring therapies in fatty tissues. 
In addition to the findings in support of our hypothesis, another important finding 
was discovered by measuring additional parameters calculated by the ARMA during 
thermal ablations.  This technique provided the unique opportunity to explore changes in 
peak-specific T2* and T1-W amplitude simultaneously with PRF-based temperature 
imaging at higher spatiotemporal resolutions than what was previously available.  We 
found statistically significant changes when Arrhenius rate dose model analysis predicted 
thermal damage to the tissue.  This could possibly be useful in verifying thermal damage 
in ablations during delivery.  Another potential use is to measure differences in these 
curves in the presence of adjuvant therapies such as chemical ablations or irradiation.   
Overall, through rigorous simulations and thermal treatments performed in 
phantoms as well as ex vivo tissues with CSI and CPD measurements, the increased 
precision and accuracy supports our hypothesis that through the use of a multi-gradient 
echo acquisition coupled with model-based spectral processing algorithms, CSI-based 
temperature maps can be generated with higher accuracy and precision compared to 
standard CPD techniques without sacrificing spatiotemporal resolution.     
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7.2 Future Directions 
This research has opened doors for new investigations not only in thermal 
therapies but also in other MR applications such as image-guided chemical ablations, T2* 
mapping, and dynamic contrast enhancement.  In terms of thermal therapies, there are 
several avenues for future work.  One is extrapolation of the lipid PRF map into water-
only areas to help correct for susceptibility, field drift and motion.  One excellent 
example would be in thermal treatments of the prostate.  If the lipid PRF map can be 
fitted by a polynomial plane, it can be used as an internal reference instead of relying on 
the changes in the water PRF alone.  This is done much the same way as referenceless 
thermometry is done with CPD-based temperature imaging (86, 158, 165). 
Another area of research is the ability of using this technique for absolute 
thermometry.  One unanswered question in MR temperature imaging is if the differences 
between water and lipid PRF values provide absolute temperature.  One current problem 
with this is a wide variation in the PRF difference between water and lipid.  Authors have 
cited several causes such as BOLD and J-coupling effects that affect the measurement in 
vivo (37).  This leads to yet another potential area of research in mapping with more than 
two peaks.  While the k-means algorithm used in this research focused on bulk methylene 
and water, the algorithm can be further investigated to higher order models to account for 
more peaks such as terminal methylene and methyl peaks.  One possible means to 
accomplish this is to look for these subsequent peaks after the primary lipid peak has 
been identified.   
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In light what was seen in our multi-parametric studies, more studies need to be 
done in vivo to provide simultaneous temperature, T2* mapping and T1-W imaging to 
validate the non-linearities seen in ex vivo tissues.  This must be correlated with histology 
to confirm damage as seen from the thermal dose and T2*/T1-W parametric imaging.  The 
goal of this work is to see if the T2* and/or T1-W imaging helps validate thermal damage 
during the delivery and, as mentioned above, if adjuvant treatments change the T2*/T1-W 
temperature sensitivities that are correlated with damage.  In addition, in some tissues a 
shift has been measured around 41 °C which corresponds to lipid bilayer disruption 
(166).   
From a computational standpoint, work is still needed to improve the computing 
performance of the spectral processing and mapping algorithms to facilitate use in real 
time for interventional procedures. Theoretically, a parallel implementation on a stand-
alone or portable workstation, which can be easily adapted to the MR scanner, is 
currently possible.  For example, implementation of the algorithms on a single graphics 
processing unit (GPU) can, at best, achieve a speed up factor of 125 (i.e., reduce the 
processing time by a factor of 125). 
The current implementation of the codes must be thoroughly profiled to find the 
computing bottlenecks and the degree of parallelism inherent to this part of the current 
algorithms must be critically evaluated.  The peak performance and speed up gains could 
be dramatically affected by the amount of inter-core communication needed by the 
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algorithm.  The possibility exists that completely different algorithms may perform better 
on these parallel computing architectures.   
Another major factor to consider is the programming language for the 
implementation.  We currently use MATLAB (MathWorks, Natick, MA) for our spectral 
and image processing.  Therefore, the quickest implementation would be to explore 
Mathwork's planned GPU support and determine if the future GPU support would be 
amenable to the goals of the project.  As an alternative, several of the national lab code 
projects have begun work implementing their open source software on GPU 
architectures.  Parallel implementation with respect to one of these code bases has several 
potential advantages and drawbacks.  For example, one code’s parallel interface hides 
low-level commands from the user and casting the algorithms in terms of its interface 
would allow future portabilty to both GPU and CPU clusters.  The CPU cluster 
environment could also be used as a fail safe for algorithms that fail in the GPU 
environment. In this situation, remote visualization capabilities would have to be 
incorporated.   It is important to note that the SM and k-means algorithms must be coded 
in C++ or be found in some other scientific computing library if it is to be implemented 
in many parallel coding structures.  The development of these codes in other languages is 
possible and is a focus of future work. 
Another application of this CSI technique is the monitoring of chemical ablations 
since many chemicals used in these procedures have MR-detectable chemical shifts.  To 
demonstrate the feasibility for providing unique information for MR-guided chemical 
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ablations, we used the MGE acquisition (16-echoes, TR/TE0=70 ms/2.1 ms, ESP=3.3 ms, 
flip angle=60, receiver bandwidth = 244 Hz/pixel, acquisition matrix = 128 x 128, 
acceleration factor = 2, voxel size = 1.6 x 1.6 x 4.0 mm3, acquisition time = 4.5 s/image) 
and the ARMA modeling to monitor the injection of 2 ml ethanol in an ex vivo bovine 
liver sample.   Ethanol is a agent used in interventions because it induces coagulation 
necrosis of tissue by protein denaturation, cellular dehydration and small vessel 
thrombosis (167).  The location and the relative concentration of the ethanol were 
determined by locating the methyl (CH3) peak versus the water peak.  Changes in the 
chemical shift, T2*, and amplitude of both the water peak and the ethanol-methyl peak 
were measured over time in a ROI. 
Figure 7-2 contains the pre and post T1-W images obtained with a fast spin echo 
(FSE) sequence in addition to T1-W amplitude made from measurements taken during 
real-time monitoring of the percutaneous injection.  Figure 7-2(a) shows the T1-W FSE 
image used to localize the needle.  Figure 7-2(b) displays the water amplitude image 60 
seconds into the ethanol injection, while Figure 7-2(c) illustrates a map of the amplitude 
of the ethanol peak overlaid on a T1-W amplitude image of water at the same time point.  
The region where the ethanol signal was located by the SM algorithm corresponds well 
with intra-treatment, T2*-corrected, T1-W images calculated using the measurements 
from the SM algorithm [Figure 7-2(b)] and the post-treatment T1-W FSE image [Figure 
5(d)].  Figure 7-2(e) illustrates the spectrum provided by our algorithm for an averaged 
signal over an ROI before and after the ethanol was percutaneously injected into the ex 
154 
 
vivo liver sample.  The methyl (CH3) peak from the ethanol is located 3.72 ppm away 
from water.  Note the similar aliasing as seen with the lipid-water phantom.  Figure 7-3 
illustrates the observed changes in the chemical shift (a), T2* (b), and amplitude (c) of the 
untreated liver, treated liver, and the methyl peak of ethanol over time.  The frequency 
difference between the water and methyl group had an uncertainty of 0.021 ppm. The 
chemical shifts in all three ROIs moved in the same direction after the injection, 
indicating changes from field drifts or susceptibility. The T2* value for ethanol steadily 
decreased [Fig. 7-3(b)], whereas the T2* of the liver tissue decreased to a value of 
approximately 24 ms, which is  27% lower than the value before the injection.  Figure 7-
3(c) shows that a 39% reduction in the T1-W amplitude for water recovered by 16% as 
the ethanol diffused from the region.   
Noise estimates in the liver tissue were 0.0022 ± 0.0005 ppm, 0.861 ± 0.272 ms, 
and 1.46 ± 0.24 % for the chemical shift, T2* and amplitude, respectively.  The chemical 
shift and T2* noise measurements, which encompassed the calculated CRLBs at the 95% 
confidence level, were calculated as 0.0023 ppm for the chemical shift and 0.902 ms for 
T2*.  At the measured SNR (40.0) and T2* (30.7 ms), the CRLB of the amplitude 
measurement was 0.34%.  The mean amplitude noise estimates did not match the CRLB 
at the 95% confidence level. 
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Figure 7-2  CSI monitoring of chemical injection of ethanol  
T1-W FSE acquisition used to localizing the injection needle (a). Image of the amplitude of water provided 
by the SM algorithm demonstrates a decrease in signal where the ethanol was injected (b). Map of the 
amplitude of the ethanol peak overlaid by a T1-W image for the amplitude of water (c). The ethanol was 
located by detecting the presence of the methyl peak.  Good correlation exists between areas of damage 
shown by a posttreatment T1-W FSE acquisition (d) and measurements calculated with the SM algorithm 
for amplitude (b) and chemical shift (c) Spectral parameters in the liver before (dashed line) and after (solid 
line) the ethanol was percutaneously injected (e).  Reprinted with permission from the American 
Association of Physicists in Medicine, (150). 
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Figure 7-3  Changes in spectral parameters over time during injection of ethanol  
The evolution of the chemical shift (a), T2* (b), and amplitude (c) for water (triangles) and ethanol’s methyl 
peak (squares) over the entire treatment time. A susceptibility shift can be seen in the water chemical shift 
in (a). The T2* for water decreased by 27% after the introduction of ethanol. (b). A 39% reduction in the 
T1-W amplitude for water recovered by 16% as the ethanol diffused from the region (c).  Reprinted with 
permission from the American Association of Physicists in Medicine, (150). 
 
Another area of future work is in the monitoring of nanoparticles that are used in 
conjunction to thermal therapies.  For instance, T2*-lowering superparamagnetic iron 
oxide (SPIO) particles have been coated with gold at a thickness where it absorbs light in 
the visible range (~808nm) to deliver thermal therapies (154).  The SPIO cores were 
added to the gold since gold is not MR-detectable but the SPIO cores give effective T2* 
contrast.  With the multi-parametric capabilities of our CSI technique, we can use the T2* 
to possibly determine the concentration of nanoshells to plan the treatment and use the 
PRF to measure the temperature during the treatment.  This CSI technique can also be 
used to determine if the increase in susceptibility from the SPIOs affect the temperature 
sensitivity coefficient of water.   In addition, this technique has the potential to monitor 
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release of gadolinium from temperature-sensitive liposomes (168).  These liposomes 
release a T1-shortening gadolinium compound which could be monitored by the T1-W 
imaging provided by the CSI technique while at the same time, monitoring temperature 
changes via the PRF.    
Along the same lines of gadolinium release, the simultaneous T1-W imaging and 
T2* mapping makes this technique attractive for simultaneous dynamic contrast 
enhancement (DCE) and dynamic susceptibility contrast (DSC) imaging.  As an example, 
Figure 7-3 shows maps when a double-bolus of gadolinium was injected into the canine 
brain under MGE monitoring.  The measurements over time are shown in Figure 7-4.  
Although for now the spatiotemporal resolution is lower with this method compared to 
other DCE methods, the use of fewer echoes as well as parallel imaging or undersampled 
reconstruction methods may increase this resolution for efficient estimation for 
simultaneous DCE and DSC measurements.       
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Figure 7-4  PRF, T2* and T1-W imaging during contrast injection 
The multi-parametric imaging provided by this technique allows simultaneous T1-W imaging and T2* 
mapping while compensating for the field inhomogeneities by calculating the field map.  The green box 
displays a spectrum in normal canine brain parenchyma and the red box displays a spectrum from a 
transmissible verneal tumor (TVT).  In addition to the changes seen in the images, a shift in the PRF and 
broadening of the linewidth due to T2* changes are seen when the gadolinium passes the blood-brain 
barrier. 
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Figure 7-5  PRF, T2* and T1-W measurements during contrast injection 
The PRF, T2* and T1-W amplitude of water was measured in 30 consecutive MGE acquisitions over 150 
seconds. Upon injection of contrast, there is a PRF shift as well as a decrease in T2* and an increase is the 
T1-W signal.   
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Appendix A:  The Cramer-Rao Lower Bound for a Sum 
of Complex, Damped Exponential 
Functions 
 The Cramer-Rao lower bound (CRLB) (148, 149) provides the lower bound on 
the uncertainty of parameter estimates from a certain model.  In this research, the model 
can be described discretely as  
( )2
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where M is the number of damped exponential functions, Ck, θk,  fk and αk is the complex 
amplitude, zero-order phase, frequency and damping factor, respectively.  w is Gaussian 
noise with zero mean.  Each real and imaginary part of w has variance σ2.  If β is the set 
of parameters that approximates y, then the probability density function for the 
measurements on the unknown parameter vector, β, can be written as 
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where N is the number of samples.  The CRLB states that for any unbiased estimate of β, 
ˆβ ,   
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where I is the Fisher information matrix defined by 
( ) ( )
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From these equations, we see that a model can approximate parameters that contain a 
lower bound in terms of uncertainty as shown in equation A-3.  The key to this analysis is 
to calculate and invert I in order to ascertain the lower bounds.  Note that I represents the 
natural logarithm of the likelihood function and E represents the expectation value. i and j 
represent each variable approximated by the model.  This will result in a 4Mx4M matrix 
there are four parameters that are to be approximated.  The matrix structure is as follows. 
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where T denotes the transpose of the matrix.  Along the diagonal, Iii can be expressed as 
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where 
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The non-diagonal elements describe the system where peaks interact with each other 
where 
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and 
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(54).  Once I is inverted, the elements in the diagonal can be multiplied by (σ/Ci)2 for the 
CRLB of αi and Ci and  (σ/2πCi)2 for fi.  For example, when M=1, the diagonal of I-1 can 
be described analytically to derive the CRLB for each parameter where 
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This analytical solution with M=1 was verified using Mathematica (Wolfram Research, 
Inc., Champaign, IL).   
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